Kristen N Ganjoo

5.0/5

37 Patient Ratings

586 Patient Reviews

Professional Summary

Education & Certifications

Board Certification: American Board of Internal Medicine, Medical Oncology (2023)
Fellowship: Indiana University School Of Medicine (2000) IN
Residency: Indiana University (1997) IN
- Internship: Indiana University (1995) IN
- Medical Education: University of South Alabama Medical Center (1994) AL
- BS, UC Davis, Biological Sciences (1989)

View More Education & Certifications

Memberships

Associate Member, American Society of Clinical Oncology (1998 - Present)
Investigator, Sarcoma Alliance for Research through Collaboration (SARC) (2008 - Present)
Physician Leader, Stanford Cancer Center- Sarcoma (2008 - Present)
- Board Member, National Comprehensive Cancer Network Task Force (NCCN)-Soft Tissue Sarcoma (2009 - Present)
- Clinical Research Group Leader-Sarcoma, Stanford University (2010 - Present)
- Member, Connective Tissue Oncology Society (CTOS) (2010 - Present)
- Member, Institutional Review Board- Stanford (2012 - Present)
- Member, Scientific Review Board- Stanford Cancer Institute (2013 - Present)

View More Memberships

Administrative Appointments

Assistant Professor of Medicine, Indiana University (2000 - 2004)
Assistant Professor of Medicine, Stanford University (2004 - 2015)
Associate Professor of Medicine, Stanford University (2015 - Present)

Publications

Primary mediastinal nonseminomatous germ cell tumors: The influence of postchemotherapy pathology on long-term survival after surgery
Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. S., Einhorn, L. H., & Brown, J. W. (1999). Primary mediastinal nonseminomatous germ cell tumors: The influence of postchemotherapy pathology on long-term survival after surgery. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 118(4), 692–700.
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma
Ganjoo, K. N., Chan, R. J., Sharma, M., & Einhorn, L. H. (1999). Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma. JOURNAL OF CLINICAL ONCOLOGY, 17(11), 3457–3460.
Lung cancer presenting with solitary bone metastases - Case 1: Metastatic adenocarcinoma to the patella
Ganjoo, K. N., Loyal, J. A., Cramer, H. M., & Loehrer, P. J. (1999). Lung cancer presenting with solitary bone metastases - Case 1: Metastatic adenocarcinoma to the patella. JOURNAL OF CLINICAL ONCOLOGY, 17(9), 2995–2997.
- Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors
  Ganjoo, K. N., Rieger, K. M., Kesler, K. A., Sharma, M., Heilman, D. K., & Einhorn, L. H. (2000). Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. CANCER, 88(5), 1051–1056.
- Germ cell tumor associated primitive neuroectodermal tumors
  Ganjoo, K. N., Foster, R. S., Michael, H., Donohue, J. P., & Einhorn, L. H. (2001). Germ cell tumor associated primitive neuroectodermal tumors. JOURNAL OF UROLOGY, 165(5), 1514–1516.
- A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: A Hoosier Oncology Group study
  Ganjoo, K. N., GORDON, M. S., Sandler, A. B., Warner, R. E., Fife, K., Poirier, S., … Loehrer, P. J. (2002). A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: A Hoosier Oncology Group study. ONCOLOGY, 62(4), 299–304.
- Unusual locations of involvement by malignancies - Case 1. Testicular plasmacytoma
  Shafqat, A., Yum, M. N., Abanour, R., & Ganjoo, K. N. (2003). Unusual locations of involvement by malignancies - Case 1. Testicular plasmacytoma. JOURNAL OF CLINICAL ONCOLOGY, 21(17), 3368–3369.
- Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: A Hoosier Oncology Group study
  Schneider, B. P., Ganjoo, K. N., Seitz, D. E., Picus, J., Fata, F., Stoner, C., … Loehrer, P. J. (2003). Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: A Hoosier Oncology Group study. ONCOLOGY, 65(3), 218–223.
- A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas - A hoosier oncology group study
  Ganjoo, K. N., Robertson, M. J., Fisher, W., Jung, S. H., McClean, J., Huh, S. Y., … Cripe, L. D. (2005). A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas - A hoosier oncology group study. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 28(2), 169–172.
- Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia
  Frankel, A. E., Surendranathan, A., Black, J. H., White, A., Ganjoo, K., & Cripe, L. D. (2006). Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia. CANCER, 106(10), 2158–2164.
- Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis
  Ganjoo, K. N., An, C. S., Robertson, M. J., Gordon, L. I., Sen, J. A., Weisenbach, J., … Horning, S. J. (2006). Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis. LEUKEMIA & LYMPHOMA, 47(6), 998–1005.
- Antiangiogenesis: A new approach to the treatment of lymphoma
  Ganjoo, K. (2007). Antiangiogenesis: A new approach to the treatment of lymphoma. LEUKEMIA & LYMPHOMA, 48(3), 454–55.
- Non-Hodgkin lymphoma of the breast
  Ganjoo, K., Advani, R., Mariappan, M. R., McMillan, A., & Horning, S. (2007). Non-Hodgkin lymphoma of the breast. CANCER, 110(1), 25–30.
- The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients
  Ganjoo, K. N., Moore, A. M., Orazi, A., Sen, J. A., Johnson, C. S., & An, C. S. (2008). The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 134(3), 381–87.
- Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy
  Ganjoo, K. N., Raman, R., Sobel, R. A., & Pinto, H. A. (2009). Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy. LEUKEMIA & LYMPHOMA, 50(4), 673–75.
- Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma
  Espinosa, I., Beck, A. H., Lee, C.-H., Zhu, S., Montgomery, K. D., Marinelli, R. J., … van de Rijn, M. (2009). Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma. AMERICAN JOURNAL OF PATHOLOGY, 174(6), 2347–56.
- I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma
  Iagaru, A., Mittra, E. S., Ganjoo, K., Knox, S. J., & Goris, M. L. (2010). I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma. MOLECULAR IMAGING AND BIOLOGY, 12(2), 198–203.
- Review of erlotinib in the treatment of advanced non-small cell lung cancer.
  Ganjoo, K. N., & Wakelee, H. (2007). Review of erlotinib in the treatment of advanced non-small cell lung cancer. Biologics : Targets & Therapy, 1(4), 335–46.
- Trabectedin: an anticancer drug from the sea
  Ganjoo, K. N., & Patel, S. R. (2009). Trabectedin: an anticancer drug from the sea. EXPERT OPINION ON PHARMACOTHERAPY, 10(16), 2735–43.
- Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec
  Ganjoo, K. N., Demetri, G. D., Jacobs, C., & Patel, S. (2009). Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. LEUKEMIA & LYMPHOMA, 50(11), 1882–1884.
- Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma Results From a Multicenter Study
  Kahl, B. S., Bartlett, N. L., Leonard, J. P., Chen, L., Ganjoo, K., Williams, M. E., … Cheson, B. D. (2010). Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma Results From a Multicenter Study. CANCER, 116(1), 106–114.
- Antiangiogenesis Agents in the Treatment of Soft Tissue Sarcomas
  Ganjoo, K., & Jacobs, C. (2010). Antiangiogenesis Agents in the Treatment of Soft Tissue Sarcomas. CANCER, 116(5), 1177–83.
- NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
  Demetri, G. D., von Mehren, M., Antonescu, C. R., DeMatteo, R. P., Ganjoo, K. N., Maki, R. G., … Wayne, J. D. (2010). NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 8, S1–S43.
- New Developments in Targeted Therapy for Soft Tissue Sarcoma
  Ganjoo, K. N. (2010). New Developments in Targeted Therapy for Soft Tissue Sarcoma. CURRENT ONCOLOGY REPORTS, 12(4), 261–65.
- Soft Tissue Sarcoma
  Demetri, G. D., Antonia, S., Benjamin, R. S., Bui, M. M., Casper, E. S., Conrad, E. U., … Wayne, J. (2010). Soft Tissue Sarcoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 8(6), 630–674.
- Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor.
  Brar, R., West, R., Witten, D., Raman, B., Jacobs, C., & Ganjoo, K. (2009). Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. Case Reports in Oncology, 2(3), 242–50.
- A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer
  Clement-Duchene, C., Krupitskaya, Y., Ganjoo, K., Lavori, P., McMillan, A., Kumar, A., … Wakelee, H. A. (2010). A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 5(11), 1821–25.
- Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour
  Ganjoo, K. N., & Patel, S. (2011). Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour. DRUGS, 71(3), 321–330.
- A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma
  Ganjoo, K. N., Cranmer, L. D., Butrynski, J. E., Rushing, D., Adkins, D., Okuno, S. H., … Chawla, S. P. (2011). A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma. ONCOLOGY, 80(1-2), 50–56.
- Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial
  Advani, R. H., Hong, F., Horning, S. J., Kahl, B. S., Manola, J., Swinnen, L. J., … Ganjoo, K. (2012). Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial. LEUKEMIA & LYMPHOMA, 53(4), 718–20.
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
  Pappo, A. S., Patel, S. R., Crowley, J., Reinke, D. K., Kuenkele, K.-P., Chawla, S. P., … Baker, L. H. (2011). R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study. JOURNAL OF CLINICAL ONCOLOGY, 29(34), 4541–4547.
- Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in Fc gamma RIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma
  Forero-Torres, A., de Vos, S., Pohlman, B. L., Pashkevich, M., Cronier, D. M., Dang, N. H., … Ganjoo, K. N. (2012). Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in Fc gamma RIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma. CLINICAL CANCER RESEARCH, 18(5), 1395–1403.
- Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer
  Riess, J. W., Logan, A. C., Krupitskaya, Y., Padda, S., Clement-Duchene, C., Ganjoo, K., … Wakelee, H. A. (2012). Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer. CANCER INVESTIGATION, 30(3), 231–35.
- Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome
  Henry, E., Villalobos, V., Million, L., Jensen, K. C., West, R., Ganjoo, K., … Telli, M. L. (2012). Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(8), 939–42.
- Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines
  von Mehren, M., Benjamin, R. S., Bui, M. M., Casper, E. S., Conrad, E. U., DeLaney, T. F., … McMillian, N. R. (2012). Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(8), 951–60.
- The Treatment Outcome for Adult Patients with Ewing's Sarcoma.
  Ganjoo, K. N., & Patel, S. (2013). The Treatment Outcome for Adult Patients with Ewing's Sarcoma. Current Oncology Reports, 15(4), 372–377.
- Review of erlotinib in the treatement of advanced non-small cell lung cancer
  Review of erlotinib in the treatement of advanced non-small cell lung cancer. (2008). Biologics; Targets & Therapy.
- Breast angiosarcomas: Case series and expression of vascular endothelial growth factor
  Breast angiosarcomas: Case series and expression of vascular endothelial growth factor. (2009). Case Reports in Oncology, 2.
- Mid-treatment PET predicts progression in hypofractionated accelerated radiation therapy for lung tumors
  Chang, C. N., Fillion, E., Chapman, C., Rao, A., Wakelee, H., Ganjoo, K., … Loo, B. W. (2009). Mid-treatment PET predicts progression in hypofractionated accelerated radiation therapy for lung tumors. JOURNAL OF THORACIC ONCOLOGY, 4(9), S939–S939.
- The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study
  Ganjoo, K. N., Witten, D., Patel, M., Espinosa, I., La, T., Tibshirani, R., … West, R. B. (2011). The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 34(1), 82–86.
- A phase II first line study of gemcitabine, carboplatin and bevacizumab in advanced stage non-squamous non-small cell lung cancer
  Clement-Duchene, C., Krupitskaya, Y., Ganjoo, K., Lavori, P., Kumar, A., Zhao, G., … Wakelee, H. (2009). A phase II first line study of gemcitabine, carboplatin and bevacizumab in advanced stage non-squamous non-small cell lung cancer. JOURNAL OF THORACIC ONCOLOGY, 4(9), S674–S674.
- TH-302, a tumor selective hypoxia activated prodrug, complements and enhances chemotherapy treatment with gemcitabine, docetaxel, pemetrexed, and doxorubicin
  Hart, C. P., Borad, M., Chawla, S. P., Infante, J. R., Ganjoo, K. N., Langmuir, V. K., … Curd, J. G. (2010). TH-302, a tumor selective hypoxia activated prodrug, complements and enhances chemotherapy treatment with gemcitabine, docetaxel, pemetrexed, and doxorubicin. EJC SUPPLEMENTS, 8(7), 124–124.
- A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.
  Ganjoo, K. N., Villalobos, V. M., Kamaya, A., Fisher, G. A., Butrynski, J. E., Morgan, J. A., … George, S. (2014). A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib. Annals of Oncology , 25(1), 236–240.
- Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines
  von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Casper, E. S., … Sundar, H. (2014). Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(4), 473–83.
- Gastrointestinal stromal tumors, version 2.2014.
  von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Casper, E. S., … Sundar, H. (2014). Gastrointestinal stromal tumors, version 2.2014. Journal of the National Comprehensive Cancer Network , 12(6), 853–62.
- Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.
  Levy, R., Ganjoo, K. N., Leonard, J. P., Vose, J. M., Flinn, I. W., Ambinder, R. F., … Denney, D. W. (2014). Active idiotypic vaccination versus control immunotherapy for follicular lymphoma. Journal of Clinical Oncology , 32(17), 1797–1803.
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
  Ganjoo, K., Hong, F., Horning, S. J., Gascoyne, R. D., Natkunam, Y., Swinnen, L. J., … Advani, R. H. (2014). Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leukemia & Lymphoma, 55(4), 768–72.
- A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study
  Pappo, A. S., Vassal, G., Crowley, J. J., Bolejack, V., Hogendoorn, P. C. W., Chugh, R., … Helman, L. J. (2014). A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study. CANCER, 120(16), 2448–2456.
- Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study
  Martin-Broto, J., Cleeland, C. S., Glare, P. A., Engellau, J., Skubitz, K. M., Blum, R. H., … Atchison, C. (2014). Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study. ACTA ONCOLOGICA, 53(9), 1173–1179.
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
  Chawla, S. P., Cranmer, L. D., Van Tine, B. A., Reed, D. R., Okuno, S. H., Butrynski, J. E., … Ganjoo, K. N. (2014). Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma. JOURNAL OF CLINICAL ONCOLOGY, 32(29), 3299-?
- Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity Fc?RIIIa Patients with Previously Treated Follicular Lymphoma.
  Ganjoo, K. N., de Vos, S., Pohlman, B. L., Flinn, I. W., Forero-Torres, A., Enas, N. H., … Wooldridge, J. E. (2015). Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity Fc?RIIIa Patients with Previously Treated Follicular Lymphoma. Leukemia & Lymphoma, 56(1), 42–48.
- Combined F-18-NaF and F-18-FDG PET/CT in the Evaluation of Sarcoma Patients
  Jackson, T., Mosci, C., von Eyben, R., Mittra, E., Ganjoo, K., Biswal, S., … Iagaru, A. (2015). Combined F-18-NaF and F-18-FDG PET/CT in the Evaluation of Sarcoma Patients. CLINICAL NUCLEAR MEDICINE, 40(9), 720–24.
- Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
  Park, M. J., Ganjoo, K. N., & Ladd, A. L. (2015). Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report. Journal of Hand Surgery, 40(8), 1620–24.
- Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
  Worhunsky, D. J., Gupta, M., Gholami, S., Tran, T. B., Ganjoo, K. N., van de Rijn, M., … Poultsides, G. A. (2015). Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? JOURNAL OF SURGICAL ONCOLOGY, 111(7), 808–12.
- Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
  Guo, X., Jo, V. Y., Mills, A. M., Zhu, S. X., Lee, C.-H., Espinosa, I., … van de Rijn, M. (2015). Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clinical Cancer Research , 21(15), 3501–11.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. ANNALS OF SURGERY, 262(4), 632–40.
- Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study.
  Ghanouni, P., Dobrotwir, A., Bazzocchi, A., Bucknor, M., Bitton, R., Rosenberg, J., … Avedian, R. (2016). Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. European Radiology, -?
- SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
  Schuetze, S. M., Wathen, J. K., Lucas, D. R., Choy, E., Samuels, B. L., Staddon, A. P., … Baker, L. H. (2016). SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma. Cancer, 122(6), 868–74.
- Soft tissue sarcoma, version 2.2014.
  von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Casper, E. S., … Sundar, H. (2014). Soft tissue sarcoma, version 2.2014. Journal of the National Comprehensive Cancer Network , 12(4), 473–483.
- First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial.
  Chawla, S. P., Papai, Z., Mukhametshina, G., Sankhala, K., Vasylyev, L., Fedenko, A., … Levitt, D. J. (2015). First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial. JAMA Oncology, 1(9), 1272–1280.
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
  Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., … Patel, S. R. (2016). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology , 34(8), 786–93.
- Soft Tissue Sarcoma, Version 2.2016 Clinical Practice Guidelines in Oncology
  von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Conrad, E. U., … Scavone, J. (2016). Soft Tissue Sarcoma, Version 2.2016 Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(6), 758–86.
- Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
  Schuetze, S. M., Bolejack, V., Choy, E., Ganjoo, K. N., Staddon, A. P., Chow, W. A., … Baker, L. H. (2016). Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer.
- Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study
  Ghanouni, P., Dobrotwir, A., Bazzocchi, A., Bucknor, M., Bitton, R., Rosenberg, J., … Avedian, R. (2017). Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. EUROPEAN RADIOLOGY, 27(2), 732–40.
- First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma A Phase 2b Randomized Clinical Trial
  Chawla, S. P., Papai, Z., Mukhametshina, G., Sankhala, K., Vasylyev, L., Fedenko, A., … Levitt, D. J. (2015). First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma A Phase 2b Randomized Clinical Trial. JAMA ONCOLOGY, 1(9), 1272–80.
- Phase 2 Study of Dasatinib in Patients With Alveolar Soft Part Sarcoma, Chondrosarcoma, Chordoma, Epithelioid Sarcoma, or Solitary Fibrous Tumor
  Schuetze, S. M., Bolejack, V., Choy, E., Ganjoo, K. N., Staddon, A. P., Chow, W. A., … Baker, L. H. (2017). Phase 2 Study of Dasatinib in Patients With Alveolar Soft Part Sarcoma, Chondrosarcoma, Chordoma, Epithelioid Sarcoma, or Solitary Fibrous Tumor. CANCER, 123(1), 90–97.
- Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
  Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682.
- Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.
  Yurkiewicz, I. R., Ganjoo, K. N., & Iagaru, A. (2018). Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT. Clinical Nuclear Medicine.
- Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma.
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors.
  Moding, E. J., Million, L., Avedian, R., Ghanouni, P., Kunder, C., & Ganjoo, K. N. (2017). Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors. Sarcoma, 2017, 2316839.
- A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma.
  Bui, N., Kamat, N., Ravi, V., Chawla, S., Lohman, M., & Ganjoo, K. N. (2018). A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma. Rare Tumors, 10, 2036361318771771.
- Circulating tumor DNA levels correlate with response to treatment in LMS patients
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Circulating tumor DNA levels correlate with response to treatment in LMS patients. CLINICAL CANCER RESEARCH, 24(2), 38–39.
- Soft Tissue Sarcoma, Version 2.2018
  von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Ganjoo, K. N., … Scavone, J. L. (2018). Soft Tissue Sarcoma, Version 2.2018. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(5), 536–63.
- Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
  Hensley, M. L., Patel, S. R., von Mehren, M., Ganjoo, K., Jones, R. L., Staddon, A., … Demetri, G. D. (2017). Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial. GYNECOLOGIC ONCOLOGY, 146(3), 531–37.
- The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma
  Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma. The Journal of Thoracic and Cardiovascular Surgery.
- Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
  Schuetze, S. M., Bolejack, V., Thomas, D. G., von Mehren, M., Patel, S., Samuels, B., … Baker, L. H. (2018). Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib. JAMA ONCOLOGY, 4(6), 814–20.
- Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor
  Brar, R., West, R., Witten, D., Raman, B., Jacobs, C., & Ganjoo, K. (2009). Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. CASE REPORTS IN ONCOLOGY, 2(3), 242–50.
- Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
  Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., … Schoffski, P. (2017). Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. LANCET ONCOLOGY, 18(8), 1089–1103.
- Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma
  Martin, P., Chen, Z., Cheson, B. D., Robinson, K. S., Williams, M., Rajguru, S. A., … Leonard, J. P. (2017). Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 178(2), 250–56.
- Results of SARC 022, a phase II multicenter study of linsitinib in pediatric and adult wild-type (WT) gastrointestinal stromal tumors (GIST).
  von Mehren, M., George, S., Heinrich, M. C., Schuetze, S., Belinsky, M. G., Janeway, K. A., … Van den Abbeele, A. D. (2014). Results of SARC 022, a phase II multicenter study of linsitinib in pediatric and adult wild-type (WT) gastrointestinal stromal tumors (GIST). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CROP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.
  Advani, R. H., Hong, F., Ganjoo, K. N., Manola, J. B., Swinnen, L. J., Habermann, T. M., & Horning, S. J. (2009). Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CROP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial. BLOOD, 114(22), 667.
- Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcoma
  Seetharam, M., Kolla, K. R., & Ganjoo, K. N. (2018). Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcoma. FUTURE ONCOLOGY, 14(23), 2323–33.
- The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
  Kamat, N. V., Million, L., Yao, D.-H., Donaldson, S. S., Mohler, D. G., van de Rijn, M., … Ganjoo, K. N. (2018). The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University. American Journal of Clinical Oncology.
- Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
  George, S., Heinrich, M., Chi, P., Razak, A., von Mehren, M., Gordon, M., … Janku, F. (2018). Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. ANNALS OF ONCOLOGY, 29.
- CDKN2A deletion as a prognostic marker: A clinico-genomic analysis of sarcoma patients.
  Nam Bui, Przybyl, J., Million, L., Van De Rijn, M., & Ganjoo, K. N. (2018). CDKN2A deletion as a prognostic marker: A clinico-genomic analysis of sarcoma patients. JOURNAL OF CLINICAL ONCOLOGY, 36(15).
- Comparison of I-131-Tositumomab (Bexxar (R)) and Y-90-Ibritumomab (Zevalin (R)) therapy of refractory/relapsed non-Hodgkin lymphoma
  Iagaru, A., Zhu, H., Mari, C., Knox, S. J., Ganjoo, K., & Goris, M. L. (2007). Comparison of I-131-Tositumomab (Bexxar (R)) and Y-90-Ibritumomab (Zevalin (R)) therapy of refractory/relapsed non-Hodgkin lymphoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 34, S168.
- Preliminary results of a Phase I study of AME-133v, an Fc-engineered humanized monoclonal antibody, in low-affinity Fc gamma RIIIa patients with previously-treated follicular lymphoma
  Forero, A., de Vos, S., Pohlman, B., Enas, N., Ganjoo, K. N., Cronier, D., … Wooldridge, J. E. (2008). Preliminary results of a Phase I study of AME-133v, an Fc-engineered humanized monoclonal antibody, in low-affinity Fc gamma RIIIa patients with previously-treated follicular lymphoma. CANCER RESEARCH, 68(9).
- Results of a Phase 3 trial evaluating safety and efficacy of specific immunotherapy, recombinant idiotype (Id) conjugated to KLH (Id-KLH) with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymph
  Levy, R., Robertson, M. J., Ganjoo, K., Leonard, J., Vose, J., & Denney, D. (2008). Results of a Phase 3 trial evaluating safety and efficacy of specific immunotherapy, recombinant idiotype (Id) conjugated to KLH (Id-KLH) with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymph. CANCER RESEARCH, 68(9).
- Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618.
  George, S., Heinrich, M. C., Razak, A. R. A., Chi, P., Gordon, M. S., Ganjoo, K. N., … Janku, F. (2018). Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618. JOURNAL OF CLINICAL ONCOLOGY, 36(15).
- Phase III study of aldoxorubicin vs investigators' choice as treatment for relapsed/refractory soft tissue sarcomas
  Chawla, S. P., Ganjoo, K. N., Schuetze, S., Papai, Z., Van Tine, B. A., Choy, E., … Levitt, D. J. (2017). Phase III study of aldoxorubicin vs investigators' choice as treatment for relapsed/refractory soft tissue sarcomas. JOURNAL OF CLINICAL ONCOLOGY, 35.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. Annals of Surgery, 262(4), 632–40.
- The impact of postoperative therapy on primary cardiac sarcoma.
  Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The impact of postoperative therapy on primary cardiac sarcoma. The Journal of Thoracic and Cardiovascular Surgery, 156(6), 2194–2203.
- Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
  Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., … Maki, R. G. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO1802374.
- Improving care with portfolio of physician-led cancer quality measures at an academic center
  Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University
  Kamat, N. V., Million, L., Yao, D.-han, Donaldson, S. S., Mohler, D. G., van de Rijn, M., … Ganjoo, K. N. (2019). The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 42(2), 166–71.
- Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K. N., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma. CLINICAL CANCER RESEARCH, 24(11), 2688–99.
- Pharmacokinetic (PK), safety, and tolerability profile of DCC-2618 in a phase I trial supports 150mg QD selected for a pivotal phase III trial in gastrointestinal stromal tumor (GIST)
  Janku, F., Heinrich, M., Razak, A., Gordon, M., Chi, P., Ganjoo, K., … George, S. (2018). Pharmacokinetic (PK), safety, and tolerability profile of DCC-2618 in a phase I trial supports 150mg QD selected for a pivotal phase III trial in gastrointestinal stromal tumor (GIST). CANCER RESEARCH, 78(13).
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
  Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J.-Y. Y., … Wagner, A. J. (2019). Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet (London, England).
- Uterine sarcomas.
  Ganjoo, K. N. (2019). Uterine sarcomas. Current Problems in Cancer.
- Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
  Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., … Maki, R. G. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. JOURNAL OF CLINICAL ONCOLOGY, 37(16), 1424-+.
- A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARCO24 trial results
  Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D. A., … Maki, R. G. (2017). A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARCO24 trial results. JOURNAL OF CLINICAL ONCOLOGY, 35.
- A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
  Bui, N. Q., Przybyl, J., Trabucco, S. E., Frampton, G., Hastie, T., van de Rijn, M., & Ganjoo, K. N. (2019). A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clinical Sarcoma Research, 9, 12.
- A phase II randomized study of CMB305 and atezolizumab versus atezolizumab in NY-ESO-1(+) soft tissue sarcoma: Analysis of immunogenicity, tumor control, and patient survival.
  Chawla, S. P., Van Tine, B. A., Pollack, S., Ganjoo, K. N., Elias, A. D., Riedel, R. F., … Maki, R. G. (2019). A phase II randomized study of CMB305 and atezolizumab versus atezolizumab in NY-ESO-1(+) soft tissue sarcoma: Analysis of immunogenicity, tumor control, and patient survival. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Responder analysis of patient-reported outcomes measurement information system (PROM'S) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study.
  Tap, W. D., Speck, R. M., Ye, X., Palmerini, E., Stacchiotti, S., Desai, J., … Gelderblom, H. (2019). Responder analysis of patient-reported outcomes measurement information system (PROM'S) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial.
  Wagner, A. J., Ravi, V., Ganjoo, K. N., Van Tine, B. A., Riedel, R. F., Chugh, R., … Dickson, M. A. (2019). ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Multi-institutional analysis of outcomes in patients with dedifferentiated chondrosarcoma (DDCS).
  Bui, N., Dietz, H., Hirbe, A. C., Ganjoo, K. N., Van Tine, B. A., Keedy, V. L., & Davis, E. J. (2019). Multi-institutional analysis of outcomes in patients with dedifferentiated chondrosarcoma (DDCS). JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- A phase II study of ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.
  Van Tine, B. A., Bui, N., Prudner, B., Bomalaski, J. S., Wu, B.-W., Chawla, S. P., … Hirbe, A. C. (2019). A phase II study of ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs)
  Janku, F., Heinrich, M., Chi, P., Razak, A. A., von Mehren, M., Gordon, M., … George, S. (2019). Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs). CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Endometriosis Malignant Transformation Review: Rhabdomyosarcoma Arising From an Endometrioma.
  Nezhat, C., Vu, M., Vang, N., Ganjoo, K., Karam, A., Folkins, A., … Nezhat, F. Endometriosis Malignant Transformation Review: Rhabdomyosarcoma Arising From an Endometrioma. JSLS : Journal of the Society of Laparoendoscopic Surgeons, 23(4).
- ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) plus olaratumab versus dox plus PBO in patients (pts) with advanced soft tissue sarcomas (STS).
  Tap, W. D., Wagner, A. J., Papai, Z., Ganjoo, K. N., Yen, C.-C., Schoffski, P., … Jones, R. L. (2019). ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) plus olaratumab versus dox plus PBO in patients (pts) with advanced soft tissue sarcomas (STS). JOURNAL OF CLINICAL ONCOLOGY, 37(18).
- Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas
  Przybyl, J., Spans, L., Lum, D. A., Zhu, S., Vennam, S., Forgo, E., … van de Rijn, M. (2019). Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas. JCO PRECISION ONCOLOGY, 3.
- Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
  Jones, R. L., Ravi, V., Brohl, A. S., Chawla, S. P., Ganjoo, K., Italiano, A., … Maki, R. (2019). Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS). ANNALS OF ONCOLOGY, 30, 683.
- Updated results of phase 1 study of ripretinib (DCC-2618), a broad-spectrum KIT and PDGFRA inhibitor, in patients with gastrointestinal stromal tumor (GIST) by line of therapy (NCT02571036)
  Chi, P., Janku, F., Heinrich, M., Ganjoo, K., Gelderblom, H., Gordon, M., … George, S. (2019). Updated results of phase 1 study of ripretinib (DCC-2618), a broad-spectrum KIT and PDGFRA inhibitor, in patients with gastrointestinal stromal tumor (GIST) by line of therapy (NCT02571036). MOLECULAR CANCER THERAPEUTICS, 18(12).
- Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas.
  Przybyl, J., Spans, L., Lum, D. A., Zhu, S., Vennam, S., Forgó, E., … van de Rijn, M. (2019). Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas. JCO Precision Oncology, 3.
- Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
  Tap, W. D., Wagner, A. J., Schöffski, P., Martin-Broto, J., Krarup-Hansen, A., Ganjoo, K. N., … Jones, R. L. (2020). Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial. JAMA, 323(13), 1266–76.
- Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens.
  George, S., Heinrich, M., Chi, P., Razak, A., von Mehren, M., Gordon, M., … Janku, F. (2018). Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 29 Suppl 8, viii576–viii577.
- Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT).
  Tap, W. D., Gelderblom, H., Stacchiotti, S., Palmerini, E., Ferrari, S., Desai, J., … Wagner, A. J. (2018). Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT). JOURNAL OF CLINICAL ONCOLOGY, 36(15).
- A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study.
  Riedel, R. F., Ballman, K. V., Lu, Y., Attia, S., Loggers, E. T., Ganjoo, K. N., … Maki, R. G. (2018). A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study. JOURNAL OF CLINICAL ONCOLOGY, 36(15).
- Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa).
  Wagner, A. J., Riedel, R. F., Van Tine, B. A., Chugh, R., Ganjoo, K. N., Cranmer, L. D., … Dickson, M. A. (2018). Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa). JOURNAL OF CLINICAL ONCOLOGY, 36(15).
- Decreased lymphocyte count at diagnosis as a marker for worse outcome in localized sarcoma.
  Bui, N., Henry, S., & Ganjoo, K. N. (2018). Decreased lymphocyte count at diagnosis as a marker for worse outcome in localized sarcoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Tenosynovial giant cell tumor of the suboccipital region - A rare, benign neoplasm in this location.
  Singh, R., Stienen, M. N., Ganjoo, K., Kolahi, K. S., Cayrol, R., Charville, G. W., … Zygourakis, C. C. (2020). Tenosynovial giant cell tumor of the suboccipital region - A rare, benign neoplasm in this location. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia.
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
  Riedel, R. F., Ballman, K. V., Attia, S., Loggers, E. T., Ganjoo, K. N., Livingston, M. B., … Maki, R. G. (2020). A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study. The Oncologist.
- Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.
  Janku, F., Abdul Razak, A. R., Chi, P., Heinrich, M. C., von Mehren, M., Jones, R. L., … George, S. (2020). Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2000522.
- Angiosarcoma of the Breast: Management and Outcomes.
  Gutkin, P. M., Ganjoo, K. N., Lohman, M., von Eyben, R., Charville, G. W., Nazerali, R. S., … Horst, K. C. (2020). Angiosarcoma of the Breast: Management and Outcomes. American Journal of Clinical Oncology.
- Nivolumab plus ipilimumab for soft tissue sarcoma: a single institution retrospective review.
  Zhou, M., Bui, N., Bolleddu, S., Lohman, M., Becker, H.-C. C., & Ganjoo, K. (2020). Nivolumab plus ipilimumab for soft tissue sarcoma: a single institution retrospective review. Immunotherapy.
- Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT.
  Wagner, A. J., Ravi, V., Riedel, R. F., Ganjoo, K. N., Van Tine, B. A., Chugh, R., … Dickson, M. A. (2020). Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I
  Janku, F., Chi, P., Heinrich, M., von Mehren, M., Jones, R. L., Ganjoo, K., … George, S. (2020). Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I. ANNALS OF ONCOLOGY, 31, S974–S975.
- NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
  von Mehren, M., Kane, J. M., Bui, M. M., Choy, E., Connelly, M., Dry, S., … George, G. V. (2020). NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network : JNCCN, 18(12), 1604–12.
- Nivolumab plus ipilimumab for soft tissue sarcoma: a single institution retrospective review
  Zhou, M., Bui, N., Bolleddu, S., Lohman, M., Becker, H.-C., & Ganjoo, K. (2020). Nivolumab plus ipilimumab for soft tissue sarcoma: a single institution retrospective review. IMMUNOTHERAPY, 12(18), 1303–12.
- Sinonasal FUS-ERG-Rearranged Ewing's Sarcoma Mimicking Glomangiopericytoma.
  Zhou, M., Ko, Y. C., Charville, G. W., & Ganjoo, K. N. (2020). Sinonasal FUS-ERG-Rearranged Ewing's Sarcoma Mimicking Glomangiopericytoma. Case Reports in Oncology, 13(3), 1393–96.
- Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
  Brewster, R., Purington, N., Henry, S., Wood, D., Ganjoo, K., & Bui, N. (2021). Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma. JAMA Network Open, 4(3), e210845.
- Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression.
  Zhou, M., Bui, N., Lohman, M., van de Rjin, M., Hwang, G., & Ganjoo, K. (2021). Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression. Case Reports in Oncology, 14(1), 459–65.
- Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma
  Pan, M., Trieu, M. K., Sidhu, M., Yu, J., Seto, T., & Ganjoo, K. (2021). Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma. CANCERS, 13(8).
- Rare and fatal complication of immune checkpoint inhibition: a case report of haemophagocytic lymphohistiocytosis with severe lichenoid dermatitis.
  Choi, S., Zhou, M., Bahrani, E., Martin, B. A., Ganjoo, K. N., & Zaba, L. C. (2021). Rare and fatal complication of immune checkpoint inhibition: a case report of haemophagocytic lymphohistiocytosis with severe lichenoid dermatitis. British Journal of Haematology.
- Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report.
  Pan, M., Ganjoo, K., & Karam, A. (2021). Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report. The Permanente Journal, 25.
- Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
  van de Sande, M., Tap, W. D., Gelhorn, H. L., Ye, X., Speck, R. M., Palmerini, E., … Healey, J. H. (2021). Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. ACTA ORTHOPAEDICA.
- Management Strategies for Patients With Epithelioid Hemangioendothelioma: Charting an Indolent Disease Course.
  Yurkiewicz, I. R., Zhou, M., Ganjoo, K. N., Charville, G. W., Bolleddu, S., Lohman, M., & Bui, N. (2021). Management Strategies for Patients With Epithelioid Hemangioendothelioma: Charting an Indolent Disease Course. American Journal of Clinical Oncology.
- Skin angiography assisted mastectomy in secondary breast angiosarcoma: Complete clinical response after neoadjuvant immunotherapy.
  Ju, T., Foster, D., Titan, A., Najjar, S., Bean, G. R., Ganjoo, K., & Wapnir, I. (2021). Skin angiography assisted mastectomy in secondary breast angiosarcoma: Complete clinical response after neoadjuvant immunotherapy. The Breast Journal.
- Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
  Chawla, S. P., Van Tine, B. A., Pollack, S. M., Ganjoo, K. N., Elias, A. D., Riedel, R. F., … Maki, R. G. (2021). Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2003452.
- Dermatopathological review of cutaneous squamous cell carcinoma events in patients with gastrointestinal stromal tumors treated with ripretinib
  Patel, A., George, S., Janku, F., Ganjoo, K., Young, R., Chi, P., … Lacouture, M. (2021). Dermatopathological review of cutaneous squamous cell carcinoma events in patients with gastrointestinal stromal tumors treated with ripretinib. ANNALS OF ONCOLOGY. ELSEVIER.
- Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour.
  George, S., Chi, P., Heinrich, M. C., von Mehren, M., Jones, R. L., Ganjoo, K., … Janku, F. (2021). Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour. European Journal of Cancer (Oxford, England : 1990), 155, 236–244.
- Safety and Feasibility of Cryoablation during Immunotherapy in Patients with Metastatic Soft Tissue Sarcoma.
  Doshi, A., Zhou, M., Bui, N., Wang, D. S., Ganjoo, K., & Hwang, G. L. (2021). Safety and Feasibility of Cryoablation during Immunotherapy in Patients with Metastatic Soft Tissue Sarcoma. Journal of Vascular and Interventional Radiology : JVIR.
- Fusion and rearrangement (RE) detection using DNA and RNA-based comprehensive genomic profiling (CGP) of sarcomas
  Ganjoo, K., Madison, R., Rosenzweig, M., Oxnard, G., Venstrom, J., Ward, A., & Schrock, A. B. (2021). Fusion and rearrangement (RE) detection using DNA and RNA-based comprehensive genomic profiling (CGP) of sarcomas. ANNALS OF ONCOLOGY. ELSEVIER.
- nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors.
  Wagner, A. J., Ravi, V., Riedel, R. F., Ganjoo, K., Van Tine, B. A., Chugh, R., … Dickson, M. A. (2021). nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2101728.
- Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review.
  Zhou, M., Javadi, C., Charville, G. W., Bui, N. Q., Harris, E. J., Poultsides, G. A., … Ganjoo, K. N. (2021). Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review. Surgical Oncology, 39, 101670.
- Use of a computer model and care coaches to increase advance care planning conversations for patients with metastatic cancer
  Gupta, D., Fardeen, T., Teuteberg, W., Seevaratnam, B., Asuncion, M. K., Alves, N., … Ramchandran, K. (2021). Use of a computer model and care coaches to increase advance care planning conversations for patients with metastatic cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Genomic Predictors of Recurrence Patterns in Localized Soft Tissue Sarcoma Treated With Radiation Therapy.
  Devine, M., Chin, A. L., Million, L., Ganjoo, K. N., Bui, N. Q., & Moding, E. J. (2021). Genomic Predictors of Recurrence Patterns in Localized Soft Tissue Sarcoma Treated With Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e316.
- Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft tissue sarcomas.
  O'Sullivan Coyne, G., Kummar, S., Hu, J., Ganjoo, K., Chow, W. A., Do, K. T., … Chen, A. P. (2021). Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft tissue sarcomas. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.
  Van Tine, B. A., Hirbe, A. C., Luo, J., Oppelt, P. J., Weiss, M. C., Eulo, V. A., … Ganjoo, K. N. (2021). Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).
  Schuetze, S., Ballman, K. V., Ganjoo, K. N., Davis, E. J., Morgan, J. A., Tinoco, G., … Rubin, B. (2021). P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations.
  Dickson, M. A., Ravi, V., Ganjoo, K. N., & Iyer, G. (2021). Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2).
  D'Angelo, S. P., Noujaim, J. C., Thistlethwaite, F., Razak, A. R. A., Stacchiotti, S., Chow, W. A., … Demetri, G. (2021). IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Genomic Predictors of Recurrence Patterns in Localized Soft Tissue Sarcoma Treated With Radiation Therapy
  Devine, M., Chin, A. L., Million, L., Ganjoo, K. N., Bui, N. Q., & Moding, E. J. (2021). Genomic Predictors of Recurrence Patterns in Localized Soft Tissue Sarcoma Treated With Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- A Retrospective Comparative Analysis of Outcomes and Prognostic Factors in Adult and Pediatric Patients with Osteosarcoma.
  Testa, S., Hu, B. D., Saadeh, N. L., Pribnow, A., Spunt, S. L., Charville, G. W., … Ganjoo, K. N. (2021). A Retrospective Comparative Analysis of Outcomes and Prognostic Factors in Adult and Pediatric Patients with Osteosarcoma. Current Oncology (Toronto, Ont.), 28(6), 5304–5317.
- Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma.
  Przybyl, J., Spans, L., Ganjoo, K., Bui, N., Mohler, D., Norton, J., … van de Rijn, M. (2022). Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma. PloS One, 17(1), e0262272.
- Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas.
  Testa, S., Bui, N. Q., Wang, D. S., Louie, J. D., Sze, D. Y., & Ganjoo, K. N. (2022). Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. Cancers, 14(2).
- Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
  Jones, R. L., Ravi, V., Brohl, A. S., Chawla, S., Ganjoo, K. N., Italiano, A., … Maki, R. G. (2022). Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial. JAMA Oncology.
- Post-operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma.
  Hall, J. C., Chang, S. D., Wilson, T. J., Ganjoo, K. N., Toland, A., Vogel, H., … Rahimy, E. (2022). Post-operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma. Cureus, 14(3), e22849.
- Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
  Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S., Martin-Broto, J., Grignani, G., … Attia, S. (2022). Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2101829.
- Current management and recent progress in desmoid tumors.
  Zhou, M. Y., Bui, N. Q., Charville, G. W., Ghanouni, P., & Ganjoo, K. N. (2022). Current management and recent progress in desmoid tumors. Cancer Treatment and Research Communications, 31, 100562.
- Local control outcomes using stereotactic body radiotherapy or surgical resection for metastatic sarcoma.
  Gutkin, P. M., von Eyben, R., Chin, A., Donaldson, S. S., Oh, J., Jiang, A., … Hiniker, S. M. (2022). Local control outcomes using stereotactic body radiotherapy or surgical resection for metastatic sarcoma. International Journal of Radiation Oncology, Biology, Physics.
- First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass
  Narayan, R. R., Charville, G. W., Delitto, D., & Ganjoo, K. N. (2022). First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass. CUREUS JOURNAL OF MEDICAL SCIENCE, 14(6).
- Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
  von Mehren, M., Kane, J. M., Agulnik, M., Bui, M. M., Carr-Ascher, J., Choy, E., … Bergman, M. A. (2022). Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(7), 815–833.
- First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass.
  Narayan, R. R., Charville, G. W., Delitto, D., & Ganjoo, K. N. (2022). First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass. Cureus, 14(6), e26356.
- Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients.
  Ramakrishnan, N., Mokhtari, R., Charville, G. W., Bui, N., & Ganjoo, K. (2022). Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients. Cancers, 14(15).
- A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
  Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D., … Maki, R. G. (2022). A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results. Cancer Medicine.
- Interactions in CSF1-driven Tenosynovial Giant Cell Tumors.
  van IJzendoorn, D. G., Matusiak, M., Charville, G. W., Spierenburg, G., Varma, S., Colburg, D. R., … van de Rijn, M. (2022). Interactions in CSF1-driven Tenosynovial Giant Cell Tumors. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Management of Patients with Newly Diagnosed Desmoid Tumors in a First-Line Setting.
  Testa, S., Bui, N. Q., Charville, G. W., Avedian, R. S., Steffner, R., Ghanouni, P., … Ganjoo, K. N. (2022). Management of Patients with Newly Diagnosed Desmoid Tumors in a First-Line Setting. Cancers, 14(16).
- Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
  Healey, J. H., Tap, W. D., Gelhorn, H. L., Ye, X., Speck, R. M., Palmerini, E., … van de Sande, M. (2022). Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN. Clinical Orthopaedics and Related Research.
- Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4])
  Lunt, C., D'Angelo, S. P., Razak, A. R. A., Wagner, M. J., Van Tine, B. A., Ganjoo, K., … Le Cesne, A. (2022). Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4]). CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program.
  Dickson, M. A., Ravi, V., Riedel, R. F., Ganjoo, K. N., Van Tine, B. A., Chugh, R., … Wagner, A. J. (2022). nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- NCCN Guidelines Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
  von Mehren, M., Kane, J. M., Riedel, R. F., Sicklick, J. K., Pollack, S. M., Agulnik, M., … Hang, L. E. (2022). NCCN Guidelines Insights: Gastrointestinal Stromal Tumors, Version 2.2022. Journal of the National Comprehensive Cancer Network : JNCCN, 20(11), 1204–1214.
- Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.
  Baniel, C., Yoo, C. H., Jiang, A., von Eyben, R., Mohler, D. G., Ganjoo, K., … Hiniker, S. M. (2022). Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy. Practical Radiation Oncology.
- Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
  Zhou, M., Bui, N., Rathore, R., Sudhaman, S., George, G. V., Malashevich, A. K., … Ganjoo, K. N. (2022). Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma. Cancers, 15(1).
- PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 OR TSC2 GENES (PRECISION I)
  Rodon, J., Demeure, M., Deming, D., Federman, N., Mckean, M., Lee, E., … Iyer, G. (2022). PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 OR TSC2 GENES (PRECISION I). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP.
- Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis.
  Bui, N. Q., Nemat-Gorgani, N., Subramanian, A., Torres, I. A., Lohman, M., Sears, T. J., … Moding, E. J. (2023). Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
  Bui, N., Dietz, H., Farag, S., Hirbe, A. C., Wagner, M. J., Van Tine, B. A., … Davis, E. J. (2023). A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma. Cancers, 15(9).
- Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy.
  Zhou, M. Y., Bui, N. Q., Charville, G. W., Ganjoo, K. N., & Pan, M. (2023). Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy. International Journal of Molecular Sciences, 24(11).
- Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
  Testa, S., Bui, N. Q., & Ganjoo, K. N. (2023). Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis. Cancer Research Communications, 3(7), 1212–1223.
- Management Strategies and Outcomes in Primary Liver Angiosarcoma.
  Ramakrishnan, N., Mokhtari, R., Charville, G. W., Bui, N., & Ganjoo, K. (2023). Management Strategies and Outcomes in Primary Liver Angiosarcoma. American Journal of Clinical Oncology.
- MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients.
  Düx, D. M., Baal, J. D., Bitton, R., Chen, J., Brunsing, R. L., Sheth, V. R., … Ghanouni, P. (2023). MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients. European Radiology.
- Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma
  Van Tine, B. A., Eulo, V., Toeniskoetter, J., Ruff, T., Luo, J., Kemp, L., … Wilky, B. A. (2023). Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma
  Van Tine, B. A., Ganjoo, K. N., Blay, J.-Y., Valverde, C., Araujo, D. M., Razak, A. R. A., … D'Angelo, S. P. (2023). The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma.
  D'Angelo, S. P., Ganjoo, K. N., Blay, J.-Y., Valverde, C., Araujo, D. M., Razak, A. R. A., … Van Tine, B. A. (2023). The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I)
  Iyer, G., Deming, D. A., Demeure, M. J., Federman, N., McKean, M., Lee, E. K., … Ahnert, J. R. (2023). Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Sex-Dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma.
  Pan, M., Zhou, M. Y., Jiang, C., Zhang, Z., Bui, N. Q., Bien, J., … Ganjoo, K. N. (2023). Sex-Dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4])
  Lunt, C., D'Angelo, S. P., Razak, A. R. A., Wagner, M. J., Van Tine, B. A., Ganjoo, K., … Le Cesne, A. (2022). Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4]). CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report.
  Zhou, M., Jawed, G., & Ganjoo, K. N. (2023). Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report. Case Reports in Oncology, 16(1), 886–892.
- Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I)
  Lee, E., Rodon, J., Demeure, M., Deming, D., Federman, N., McKean, M., … Iyer, G. (2023). Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I). GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE.
- Response to treatment with nab-sirolimus among patients with primary uterine PEComa: A sub analysis from AMPECT
  Palma, N., Navarro, W., Ravi, V., Dickson, M., Ganjoo, K., Ding, L., … Wagner, A. (2023). Response to treatment with nab-sirolimus among patients with primary uterine PEComa: A sub analysis from AMPECT. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE.
- Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
  Deming, D. A., Ahnert, J. R., Demeure, M. J., Federman, N., McKean, M., Lee, E. K., … Iyer, G. (2023). Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
  Iyer, G., Demeure, M. J., Deming, D. A., Federman, N., McKean, M., Lee, E. K., … Itri, L. M. (2023). Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review.
  Zamarud, A., Marianayagam, N. J., Sekar, V., Testa, S., Park, D. J., Yener, U., … Meola, A. (2023). Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review. Journal of Neurosurgery. Spine, 1–13.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Safety Study of MGD009 in B7-H3-expressing Tumors

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Selinexor in Advanced Liposarcoma

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Specializing In

Practice Locations

Sarcoma Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Sarcoma Program in Palo Alto

900 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(37 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(586 reviews)

Dr. Ganjoo answered many questions I had concerning my MRI and chest x-ray results. Also answered many other questions regarding: my Sarcoma, iimmunology, Contact with other Sarcoma Ctrs. Re: new treatments and. Clinical trials and how these centers share info with Stanford Sarcoma Ctr. I requested resource info re: counseling as I deal with my Sarcoma still in my bodyand other stressful situations in my current life. Dr.Ganjoo will have Francis, her Social Worker get in touch with me. I have been a patient of Dr.Ganjoo for 14 yrs. and I feel most comfortable asking questions , discussing my fears, etc. She is always reassuring and I always leave my appts more informed and less stressed .

Dec 2024

•

Verified SHC Patient

Thank you so much for making time to have a call. I am relieved my CT scan was clear! Thank you for giving me a plan of action, and the reasoning for the plan. I look forward to working with you! Thank you!

Dec 2024

•

Verified SHC Patient

I had a great stay at Stanford and all of the staff took very good care me. Thank you so much.

Dec 2024

•

Verified SHC Patient

Dr. Ganjoo is exceptional. She is extremely knowledgeable and really listens and addresses my concerns.

Dec 2024

•

Verified SHC Patient

Dr. Ganjoo is extremely knowledgeable about my cancer and my medical history. She is friendly, open to all questions, and not rushed. I feel very fortunate that she is my oncologist.

Dec 2024

•

Verified SHC Patient

She is expert, competent, caring, thorough, kind, considerate, patient, and open always. I always enjoy our appointments, and feel confident about our plans.

Dec 2024

•

Verified SHC Patient

Answers all my questions, doesn't make you feel rushed or stupid for asking alot of questions. Totally trust her judgment on what needs to be done to treat what is wrong with you. Very knowledgeable in her field. Love her!

Nov 2024

•

Verified SHC Patient

Dr. Ganjoo was pleasant, kind and knowledgeable. She explained things well and was patient (I was very nervous about this visit and what is going on with me.)

Nov 2024

•

Verified SHC Patient

I really appreciate the time she took today to go over everything with me and discuss my medication, schedule my MRIs over the phone and inform me of what to look out for in the future and prognosis of my disease.

Nov 2024

•

Verified SHC Patient

Dr. Ganjoo is caring, empathetic and truly listens.

Nov 2024

•

Verified SHC Patient

Dr Ganjoo was so sensitive and warm in her discussion with me and was clear and gave me all the information that I need to feel more comfortable about what the next steps would be.

Nov 2024

•

Verified SHC Patient

Dr. Ganjoo is a very nice Doctor

Nov 2024

•

Verified SHC Patient

Dr. Ganjoo is an absolute treasure. She is always on time for my physical or video appointments. She is absolutely thorough. I am super grateful that Iâ€™m able to be treated here at Stanford.. Giving me hope to be able to live longer with stage 4 LMS. I have never been excited to get treatments! Please do whatever you can to keep Dr. Ganjoo at Stanford.

Nov 2024

•

Verified SHC Patient

She is a wonderful, warm, caring and knowledgeable and experienced doctor.

Nov 2024

•

Verified SHC Patient

Kristen Ganjoo is the most personable doctor I have ever met. She seems to really care and listen to my needs. Her availability has been a lifeline to me. There really is no comparison as to her abilities, intelligence, knowledge, kindness, and caring.

Nov 2024

•

Verified SHC Patient

Amazing Dr. Truly a life saver

Nov 2024

•

Verified SHC Patient

An excellent caring doctor.

Nov 2024

•

Verified SHC Patient

Outstanding level of knowledge and care!

Nov 2024

•

Verified SHC Patient

She is saving my life!

Oct 2024

•

Verified SHC Patient

Dr. Ganjoo is one of the most kind, compassionate and professional doctors I have ever met. She always takes care of me with a smile. She is a great oncologist. God Bless her :) Kanchanpreet Sohal

Oct 2024

•

Verified SHC Patient

Kristen Ganjoo is a kind, thoughtful doctor who speaks clearly and has a very calming, sweet voice that relaxes me. I trust her to provide the best medical care for me. She listens well, always answers my questions, and seems knowledgeable. I am grateful for her medical care.

Oct 2024

•

Verified SHC Patient

Highly recommend!

Oct 2024

•

Verified SHC Patient

Dr Ganjoo, answered all my questions and I was very satisfied with the visit.

Sep 2024

•

Verified SHC Patient

I love Dr. Ganjoo. She is the very best.

Sep 2024

•

Verified SHC Patient

Dr Ganjoo was very thorough with her assessment and glad she is my specialist

Sep 2024

•

Verified SHC Patient

Dr. Kristen Ganjoo is amazing! Sheâ€™s very pleasant, kind, compassionate and understanding. Itâ€™s always a pleasure to see her and speak with her. Sheâ€™s very helpful in explaining everything so that we completely understand.

Sep 2024

•

Verified SHC Patient

Dr. Ganjoo is incredibly knowledgeable she made me feel very comfortable and took the time to answer all my questions.

Sep 2024

•

Verified SHC Patient

Awesome!!â€™

Sep 2024

•

Verified SHC Patient

Awesome doctor

Aug 2024

•

Verified SHC Patient

Dr. Ganjoo is wonderful. She is very empathetic and reassures me by answering my concerns with information and encouragement. I could not ask for a better physician. Give this woman a raise. ðŸ˜‰

Aug 2024

•

Verified SHC Patient

Very helpful and explained everything extremely well

Aug 2024

•

Verified SHC Patient

Dr. Ganjoo is a very caring.doctor. She provided excellent information and answered my questions. She is a very compassionate person.

Aug 2024

•

Verified SHC Patient

Dr. Ganjoo is so knowledgeable and reassuring. I can see why she is so well thought of and gets so many referrals. I feel very fortunate to be in her care.

Jul 2024

•

Verified SHC Patient

Dr. Ganjoo is an excellent doctor who answers all my questions and concerns.

Jul 2024

•

Verified SHC Patient

Dr Ganjoo is a great doctor. She is on time, very clear and open She communicates well and demonstrates a real concern for me.

Jul 2024

•

Verified SHC Patient

Dr Ganjoo was extremely helpful in rely information of all possible treatments. Made the video visit feel comfortable and made sure to get to know the patient more than just medically. Looking forward to having Dr Ganjoo as part of my healthcare team

Jul 2024

•

Verified SHC Patient

Dr. Ganjoo is knowledgeable and personable. She has a sense of humor. I never feel rushed when talking to her.

Jul 2024

•

Verified SHC Patient

Dr. K. Ganjoo is excellent with her communications and medical care. She listens and gives me peace of mind. I value her as my specialist, especially as the initial medical issue was concerning. She and her team are very prompt in providing me with an immediate appointment, for any concerning matter or development which may arise with me. Very grateful to her, the team and to Stanford Health Care!

Jul 2024

•

Verified SHC Patient

Feel very fortunate to have her as my doctor.

Jul 2024

•

Verified SHC Patient

Love her! Very professional but at the same time her caring nature comes through. Excellent oncologist and I'm so glad she is heading my care team. Gives me hope about my situation â ¤

Jul 2024

•

Verified SHC Patient

Dr. Ganjoo really professional and such a great doctor. She really knows whatâ€™s the best for you

Jun 2024

•

Verified SHC Patient

She is the BEST in every way!!!!

Jun 2024

•

Verified SHC Patient

Very pleased with her as my doctor.

Jun 2024

•

Verified SHC Patient

Dr. Ganjoo is very friendly and informative. I trust that I am getting good care.

Jun 2024

•

Verified SHC Patient

Dr.Ganjoo is very thorough and explains well. I feel very comfortable, addressing any concerns with her. So happy that she is my oncologist.

Jun 2024

•

Verified SHC Patient

Kristen Ganjoo is an excellent oncologist.

Jun 2024

•

Verified SHC Patient

Dr Ganjoo was very positive in her discussion re my cancer prognosis. She also gave me confidence that sheâ€™s had a great deal of experience with leiomysarcoma patients. That gives me confidence when speaking with her.

Jun 2024

•

Verified SHC Patient

She is the best!

Jun 2024

•

Verified SHC Patient

Kristen Ganjoo is very knowledgeable with the type of cancer that I have and is providing me with the treatment she feels is necessary.

Jun 2024

•

Verified SHC Patient

Knowlegable sweet caring doctor

Jun 2024

•

Verified SHC Patient

She is very thorough, and explained it in a way I could understand .

Jun 2024

•

Verified SHC Patient

Dr. Ganjoo is very pleasant, professional and patient.

May 2024

•

Verified SHC Patient

The medical staff are excellent and so caring and knowledgeable.

May 2024

•

Verified SHC Patient

I appreciate her medical expertise and positive outlook for my treatment. I feel blessed to have her leading my course of treatment.

May 2024

•

Verified SHC Patient

She seems kind and caring. and extremely proficient

May 2024

•

Verified SHC Patient

Dr Ganjoo devoted a great deal of time with us especially showing and explaining the PET scan

May 2024

•

Verified SHC Patient

Love Dr Ganjoo- so reassuring

May 2024

•

Verified SHC Patient

Very, polite great attitude and delivers the news good or bad with a genuine caring concern. Very happy with Dr. Ganjoo

Apr 2024

•

Verified SHC Patient

Thank you for your care

Apr 2024

•

Verified SHC Patient

Dr. Ganjoo is extremely personable and is very good at explaining things and answering questions.

Apr 2024

•

Verified SHC Patient

Dr Ganjoo is excellent! She is friendly, listens well, thinks outside the box, always optimistic, makes me feel listened to and that she is monitoring my health condition closely, she gets things done. I am so lucky to be under her care.

Apr 2024

•

Verified SHC Patient

Dr Ganjoo is an amazing doctor. Very caring and she really calms your fear with her knowledge. I feel very blessed to have found her.

Apr 2024

•

Verified SHC Patient

Sheâ€™s smart professional warm caring and I am so grateful to have her on my team

Apr 2024

•

Verified SHC Patient

I can't imagine having anyone else as my Doctor. Next to my husband, who is the most caring and supportive man alive, she is my rock. She represents Stanford very well. She is caring, professional and she listens. I'm very blessed to have her and so are you....

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo has been my Oncology doctor since 2014 and she has always been very compassionate, professional and polite every time I went in for my appointments. Her care team has also been professional and kind. I will always be grateful for them and that everything turned out well for me after ten years. Good luck to them and all their patients!

Mar 2024

•

Verified SHC Patient

Excellent doctor and care provider Easy to communicate with Reachable Knowledgeable Caring Thorough Above and beyond !

Mar 2024

•

Verified SHC Patient

An excellent Doctor that has been very helpful to me. Highly recommend Dr. Ganjoo

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo is a kind and excellent doctor

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo is the best!!!! I feel so lucky to be under her care.

Mar 2024

•

Verified SHC Patient

She is an exceptional doctor. Expert in her field ! But she is also kind, interested, patient, and caring. Dr. Ganjoo is a real treasure. Stanford is fortunate to have her.

Mar 2024

•

Verified SHC Patient

Kristen is very thorough and always explains things well and easy to understand. It is obvious that she really cares for her patients. I feel fortunate to have her on my healthcare team!!

Mar 2024

•

Verified SHC Patient

I trust her with my life !

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo is wonderful. She is easily able to transmit medical information but her warmth and compassion is her strongest attribute. I feel so grateful that I have been referred to her for my care.

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo was extremely personable and thorough.

Mar 2024

•

Verified SHC Patient

I am grateful that I had the opportunity to speak with Dr. Ganjoo because she is an expert in the field of Cancer, specifically treating patients with Sarcomas. I am a Kaiser patient and that same level of expertise isn't available to me.

Mar 2024

•

Verified SHC Patient

I am grateful to have Dr. Ganjoo on my team. To have a specialist in sarcoma oversee my treatment is comforting.

Mar 2024

•

Verified SHC Patient

Very informative and helpful visit -- thank you!

Mar 2024

•

Verified SHC Patient

She is amazing. She's been my husband's doctor since 2015. She always puts the patient 1st. By that I mean the whole body of the patient is important not just treating any cancer.

Mar 2024

•

Verified SHC Patient

Very satisfied and grateful for her work.

Mar 2024

•

Verified SHC Patient

Dr. Ganjoo really listens and answers all my questions She is very kind and empathetic.

Feb 2024

•

Verified SHC Patient

Dr. Kristen Gangoo is a joy to discuss my medical care and needs. She is open, caring and always looking for a way to make my life better.

Feb 2024

•

Verified SHC Patient

She is very kind and knowledgeable about my illness

Feb 2024

•

Verified SHC Patient

She is an amazing Doctor but also personable, understands your concerns and help ease your fears good or bad and I honestly feel she wants to take the vary best care of you with all options. I am in good hands for sure!

Feb 2024

•

Verified SHC Patient

She was very accommodating and kind

Feb 2024

•

Verified SHC Patient

I canâ€™t say enough about her. Patient, calm, thorough, warm, beyond brilliant and well-informed, open and objectiveâ€¦â€¦ these words donâ€™t begin to describe how I feel.

Feb 2024

•

Verified SHC Patient

Sheâ€™s articulate and confident in what she explains and recommends

Feb 2024

•

Verified SHC Patient

She is great!!!

Feb 2024

•

Verified SHC Patient

I was very impressed with Dr. Ganjooâ€™s knowledge and her friendly manner. I felt very good about her recommendations to me.

Feb 2024

•

Verified SHC Patient

Love Kristen Ganjoo. Very professional. Very personable. Very attentive and caring.

Feb 2024

•

Verified SHC Patient

Nice Doctor! Dr. Ganju is a very knowledgeable doctor. Each meeting is held with attention to detail in a pleasant, friendly atmosphere.

Feb 2024

•

Verified SHC Patient

As a,ways, Dr Ganjoo was empathetic and wonderful!

Feb 2024

•

Verified SHC Patient

Excellent doctor

Feb 2024

•

Verified SHC Patient

Dr Ganjoo is a delightful Doctor to deal with. She has been very helpful and guided me through the correct treatment. She answered all of my questions.

Feb 2024

•

Verified SHC Patient

Dr. Ganjoo is an outstanding physician

Feb 2024

•

Verified SHC Patient

Dr. Ganjoo was very knowledgeable and helpful.

Feb 2024

•

Verified SHC Patient

Dr Ganjoo is an excellent doctor, I am comfortable with her.

Feb 2024

•

Verified SHC Patient

Dr Ganjoo is very thorough and makes sure all my questions are answered during our visits.

Feb 2024

•

Verified SHC Patient

She is an incredibly responsive and thoughtful practitioner. I feel confident that Dr. Ganjoo is paying full attention to me as her patient and as a person. She spends time reviewing my history and providing thorough guidance on how I can ensure continued good health.

Feb 2024

•

Verified SHC Patient

Listens, explains options well.

Jan 2024

•

Verified SHC Patient

Dr Ganjoo is wonderful. I felt that at our first meeting that she truly had my back fighting this cancer. She has been extremely positive and I feel that she is very knowledgeable about sarcoma cancer. I'm convinced that she has saved my life. I know that my cancer might come back but with her in my corner we can beat it again.

Jan 2024

•

Verified SHC Patient

I am very happy with my care with Kristen Ganjoo

Dec 2023

•

Verified SHC Patient

I feel that I am in the best of hands receiving my care from Dr. Kristen Ganjoo.

Dec 2023

•

Verified SHC Patient

Dr. Ganjoo is very caring and compassionate.

Dec 2023

•

Verified SHC Patient

Always on top of my situation and makes sure I understand her input.

Dec 2023

•

Verified SHC Patient

Dr Ganjoo is excellent. Very easy to talk with, gives easy to understand instructions. I love the way she reassures me. I have so much confidence in her as my physician. Sheâ€™s a keeper. Thank you.

Dec 2023

•

Verified SHC Patient

A wonderful doctor and staff

Dec 2023

•

Verified SHC Patient

Thank you! Happy holidays Dr. Ganjoo!

Dec 2023

•

Verified SHC Patient

Dr. Ganjoo is always friendly and patient with me, and very thorough. She takes time to answer all my questions completely.

Dec 2023

•

Verified SHC Patient

I have been working with Dr. Ganjoo for 13 years and always feel she is doing the best for me with my medical diagnosis . Sheâ€™s knowledgeable and always encouraging. She always gives me hope and makes me feel better.

Dec 2023

•

Verified SHC Patient

She is great. We have had great confidence in her in a difficult journey. We believes she cares about my health.

Dec 2023

•

Verified SHC Patient

Welcoming, thorough, whole health- not related to the tumor, forward planner â€” I felt connected , like I could trust her. I am grateful for the opportunity to have consulted her and to have had the conversation we did! Much appreciated!

Dec 2023

•

Verified SHC Patient

Excellent Pysician. Dr Ganjoo is very thoughtful, compassinonate, personalble, and well informed . She was very concerned about my medical needs.

Nov 2023

•

Verified SHC Patient

Dr. Ganjoo makes a video visit very pleasant and informative.

Nov 2023

•

Verified SHC Patient

Dr. Ganjoo is the best. She is expert, thorough, kind, caring, and thorough. She communicates wonderfully and answers all questions. I am very very lucky that she is my doctor.

Nov 2023

•

Verified SHC Patient

She is a comunicative, knowable and caring Doctor. Her ability to understand my health problems are very reasuring.

Nov 2023

•

Verified SHC Patient

Dr. Ganjoo is direct, warm, knowledgeable, and willing to collaborate in difficult circumstances. She really seems to care about her patients.

Nov 2023

•

Verified SHC Patient

I feel so fortunate that my doctor referred me to Kristen Ganjoo. She saved my life. I am grateful to have her as my doctor .

Nov 2023

•

Verified SHC Patient

Excellent Doctor he always understands my concerns

Nov 2023

•

Verified SHC Patient

Outstanding

Nov 2023

•

Verified SHC Patient

You are the best!

Nov 2023

•

Verified SHC Patient

Very appreciative of her work.

Oct 2023

•

Verified SHC Patient

She is an amazing physician. She saved my life. Will forever be greatful for her ability, compassion and patience.

Oct 2023

•

Verified SHC Patient

Dr Ganjoo is an excellent Dr very thorough and compassionate.

Oct 2023

•

Verified SHC Patient

Dr. Ganjoo is excellent as usual. Friendly, answers all my questions, and of course in the top of her field.

Oct 2023

•

Verified SHC Patient

I talked about her on the prior comment box

Oct 2023

•

Verified SHC Patient

She's a terrific doctor and caring human being. I'm blessed to have her as my doctor.

Oct 2023

•

Verified SHC Patient

Excellent doctor and takes time to answer any questions.

Oct 2023

•

Verified SHC Patient

She is so kind and caring

Oct 2023

•

Verified SHC Patient

Thank you from the bottom of my Heart . You are an amazing doctor. Thank you again.

Oct 2023

•

Verified SHC Patient

Dr Ganjoo always answers my questions in understandable language.

Oct 2023

•

Verified SHC Patient

Thank you for todayâ€™s video visit! We appreciate all your guidance and support!

Oct 2023

•

Verified SHC Patient

She is optimistic and encouraging.

Sep 2023

•

Verified SHC Patient

Sheâ€™s amazing

Sep 2023

•

Verified SHC Patient

I appreciate her high level of expertise and compassionate care.

Sep 2023

•

Verified SHC Patient

provided outstanding personalized oncology care

Sep 2023

•

Verified SHC Patient

She was most kind, knowledgeable and informative informative. She gave me excellent information in a way which I could understand and she gave me hope.

Sep 2023

•

Verified SHC Patient

Wonderful doctor providing excellent care.

Sep 2023

•

Verified SHC Patient

Kind, clear, professional.

Sep 2023

•

Verified SHC Patient

Excellent physician, very good listener. Compassionate.

Sep 2023

•

Verified SHC Patient

Excellent Doctor !!

Aug 2023

•

Verified SHC Patient

Very excellent Doctor

Aug 2023

•

Verified SHC Patient

Excellent dr

Aug 2023

•

Verified SHC Patient

Awsome dedicated doctor who cares about her patients!

Aug 2023

•

Verified SHC Patient

Dr Ganjoo was very attentive and very knowledgeable. I enjoyed talking with her. She explained everything thoroughly.

Aug 2023

•

Verified SHC Patient

It was my first visit with her and Iâ€™m very satisfied with our visit and I trust that sheâ€™s a great Dr. To help me with my health. Thank you

Aug 2023

•

Verified SHC Patient

Great first meeting. Very helpful and made me feel confident in her

Aug 2023

•

Verified SHC Patient

I am grateful for Dr. Ganjooâ€™s knowledge and expertise. I trust her with my care.

Jul 2023

•

Verified SHC Patient

I have been blessed to be a patient of Dr Gangoo for years. She is professional, attentive to my case, and instrumental in providing the cancer treatment I need.

Jul 2023

•

Verified SHC Patient

Iâ€™ve always been extremely satisfied with my video visits with Dr. Ganjoo.

Jul 2023

•

Verified SHC Patient

Dr. Ganjoo is very thorough and knowledgeable. She has excellent personal skills and I always feel like she is truly invested in my health and recovery.

Jul 2023

•

Verified SHC Patient

Excellent doctor, answers all my questions and gives excellent advice.

Jul 2023

•

Verified SHC Patient

She is very thorough and always answers our questions.

Jul 2023

•

Verified SHC Patient

Very thorough, completely understood the issues. Extremely happy with her care.

Jul 2023

•

Verified SHC Patient

Dr. Ganjoo is a treasure: knowledgeable, kind, caring, articulate, concise, helpful, and open. She would receive my highest recommendation. A+

Jul 2023

•

Verified SHC Patient

Excellent Doctor

Jul 2023

•

Verified SHC Patient

She was wonderful! Was very knowledgeable, prepared, compassionate and not rushed at all.

Jul 2023

•

Verified SHC Patient

Dr. Ganjoo is an awesome, caring person who takes great care in her dealings with me. I appreciate her very much.

Jul 2023

•

Verified SHC Patient

Sweet. Nice , excellent.

Jul 2023

•

Verified SHC Patient

Very kind and caring doctor. Very thorough.

Jun 2023

•

Verified SHC Patient

She is always ready for the video visit and weâ€™ll prepared for my questions.

Jun 2023

•

Verified SHC Patient

She is a dedicated smart and compassionate doctorâ€¦so few around.

Jun 2023

•

Verified SHC Patient

Sheâ€™s very encouraging and optimistic. She explains things well and answers Any questions I have. Iâ€™ve been honest with her and feel sheâ€™s been the same with me.

Jun 2023

•

Verified SHC Patient

Dr. Ganjoo is very caring.

Jun 2023

•

Verified SHC Patient

As always, I appreciate all that you do.

Jun 2023

•

Verified SHC Patient

Dr Ganjoo has always expressed a positive outlook with me even through difficult times and this really Carrieâ€™s over to me and helps give me optimism. I really appreciate her calm manner.

Jun 2023

•

Verified SHC Patient

Dr. Ganjoo is always friendly and caring. I appreciate her positivity and continued interest in my health.

Jun 2023

•

Verified SHC Patient

I'm happy so far. I also had positive news.

May 2023

•

Verified SHC Patient

Dr. Ganjoo is very knowledgeable and decisive dealing with my case. Additionally, she recommended links to websites that will be informative and helpful to me. I am grateful to have Dr. Ganjoo and her colleagues at Stanford working to improve my health.

May 2023

•

Verified SHC Patient

I would go all the way down to Stanford, every single day to see Dr. Ganjoo. I am blessed to have Dr. Ganjoo (and Dr. Poultsides as well) and have told them many times. If my seeing anyone else, anywhere would jeopardize my having her for my doctor, I wouldn't do it. I just told her today that the reason I'm alive is because of them. Dr. Ganjoo always takes the time to answer any questions i have, as well as my husbands. She works with me on options and knows my body systems. I am having radiation because I trust Dr. Ganjoo. Not to heal me, but to give me any and all information so that I can make informed decisions. I trust her to do that and she has throughout this ordeal. It wasn't an easy trust as I'd already had a cancer doctor walk out on me because of a question. I have only positive thoughts and experiences with Dr. Ganjoo and I can't imagine having anyone else for my doctor.

May 2023

•

Verified SHC Patient

The staff is truly wonderful and make me feel so welcomed and taken care of

May 2023

•

Verified SHC Patient

Compassion

May 2023

•

Verified SHC Patient

Dr. Ganjoo was very thorough, answered all my questions, and went through the entire plan with me. She seemed genuinely invested in my health and overall outcome.

May 2023

•

Verified SHC Patient

Very helpful and caring. Very easy to work with

May 2023

•

Verified SHC Patient

Dr Ganjoo was well aware and helped

May 2023

•

Verified SHC Patient

Dr. Kristen Ganjoo is extremely compassionate, understanding, listens to my concerns, willing to consider the direction I would like and is focused on my GIST cancer care!

May 2023

•

Verified SHC Patient

Love Dr. Ganjoo.

May 2023

•

Verified SHC Patient

Personable and Competent

May 2023

•

Verified SHC Patient

Dr. Ganjoo is amazing! Sheâ€™s very kind, considerate and understanding to our situation. She took the time to explain everything and answer our questions. She is very informative. I would highly recommend her.

May 2023

•

Verified SHC Patient

Excellent doctor.

May 2023

•

Verified SHC Patient

Dr Ganjoo was very warm and easy to talk to. She answered all of my questions thoughtfully and provided much new information clearly. She did not rush me and was very kind and comforting.

Apr 2023

•

Verified SHC Patient

Dr. Ganjoo is always very positive and encouraging with me and I am very comfortable to ask any questions with her and her team.

Apr 2023

•

Verified SHC Patient

Very professional , nice doctor very thorough, answered all my questions directly.,

Apr 2023

•

Verified SHC Patient

Excellent physician.

Apr 2023

•

Verified SHC Patient

Professional, personal, knowledgeable with positive attitude.

Apr 2023

•

Verified SHC Patient

Smart, respectful, a genuinely caring physician.

Apr 2023

•

Verified SHC Patient

Very professional and thorough

Mar 2023

•

Verified SHC Patient

Dr. Kristen Ganjoo is an excellent doctor in all ways. She is extremely knowledgeable and expert in her field specialty. She is clear and concise in answering questions and explaining things. She is very kind and open and makes a patient feel good about his situation. Ansolutely A++++!

Mar 2023

•

Verified SHC Patient

Excellent in all areas!

Mar 2023

•

Verified SHC Patient

Always happy to see Dr. Ganjoo- I feel confident I am in good hands

Mar 2023

•

Verified SHC Patient

Very great amazing doctor

Mar 2023

•

Verified SHC Patient

She is professional, conscientious and knowledgeable.

Feb 2023

•

Verified SHC Patient

Thank you so much for your help and for hearing me.

Feb 2023

•

Verified SHC Patient

She always does an amazing job!! I love how knowledgeable she is on recommended treatments for my type of cancer.

Feb 2023

•

Verified SHC Patient

Sheâ€™s been doing great

Feb 2023

•

Verified SHC Patient

Dr. Ganjoo is very empathetic and has a wonderful â€œbedsideâ€ manner. Iâ€™m always surprised by how much she remembers about my personnel life. Definitely a great doctor!

Feb 2023

•

Verified SHC Patient

Extremely helpful and first doctor to put me at ease. Grateful to have her taking care of my health.

Feb 2023

•

Verified SHC Patient

Excellent doctor. Explained everything very well and provided options

Feb 2023

•

Verified SHC Patient

Excellent visit

Feb 2023

•

Verified SHC Patient

Thank you!

Feb 2023

•

Verified SHC Patient

Stanford is lucky to have her. I am grateful for her care. I am still here today because of her knowledge and expertise with my type of cancer. She is so positive and is truly a wonderful doctor. I am fortunate that I was referred to her specifically.

Feb 2023

•

Verified SHC Patient

Dr. Ganjoo is very personable and professional. She made me feel well taken care of.

Feb 2023

•

Verified SHC Patient

Dr. Ganjoo came across warm and confident. She seemed to know what she was dealing with concerning my cancer which was also encouraging in my situation. I have been lucky to be working with great professional people but it's really nice to be around a specialist who seemed oriented in my particular type of cancer and potential alternative medicine as well as being nice and kind.

Jan 2023

•

Verified SHC Patient

She is the best!

Jan 2023

•

Verified SHC Patient

Dr GAnjoo addresses my symptoms and concerns.

Jan 2023

•

Verified SHC Patient

I was pleased with the visit, first with the nurse, then with the doctor too. She listened to my concerns and answered my questions and helped put a definite plan in place.

Jan 2023

•

Verified SHC Patient

She is very easy to talk to A very good listener. Very knowledgeable with Sarcomas

Jan 2023

•

Verified SHC Patient

She is always has encouraging words for me.

Jan 2023

•

Verified SHC Patient

Always a pleasure speaking with Kristen Ganjoo.

Jan 2023

•

Verified SHC Patient

Sheâ€™s very thorough and careful to accommodate me since I live three hours away. Sheâ€™s working with my oncologist here in my town so they are a team as well.

Jan 2023

•

Verified SHC Patient

She is a very thorough doctor. And I like her upbeat personality.

Jan 2023

•

Verified SHC Patient

I am happy and lucky to be under the care of Dr. Ganjoo. She sees to it that my questions are answered. Not only is she pleasant but caring too. I had my recent mri and she messaged me right away on the results which is totally a good thing to lessen my anxiety on it.

Jan 2023

•

Verified SHC Patient

Extremely knowledgable professional with great communication skills. Very thorough and takes the time to explain difficult issues. Caring and very likeable personality that gives you the feeling that you are in good hands.

Dec 2022

•

Verified SHC Patient

Very professional, speaks thoughtful and takes the time to listen. Asked the right questions.

Dec 2022

•

Verified SHC Patient

Dr. Ganjoo is simply amazing. She is that highly unusual blend of cutting-edge knowledge and deep compassion that are so hard to find in the same doctor. I truly believe that her care of me has quite literally helped save my life.

Dec 2022

•

Verified SHC Patient

I appreciate Dr. Ganjoo so much. Despite the difficult topics she must often deal with, she is empathetic, knowledgeable, and easy to communicate with.

Dec 2022

•

Verified SHC Patient

I look forward to all my appointments with Dr.Ganjoo. She is so down to eart and pleasant and very caring. She answers all my questions and relays information so easy to understand.

Dec 2022

•

Verified SHC Patient

It is lways food to meet Dr. Ganjoo in person to discuss the symptoms and hear the resolutions.

Dec 2022

•

Verified SHC Patient

Dr Ganjoo is great. I have complete trust and faith in her.

Dec 2022

•

Verified SHC Patient

Dr. Ganjoo is a joy to work with. She is always courteous and warm and demonstrates an earnest interest in the concerns and wellbeing of her patient. Her experience and expertise are much appreciated and her style is very approachable and elicits a sense of trust and confidence in her clinical skills.

Dec 2022

•

Verified SHC Patient

She is very knowledgeable and explains things very well. She did not pressure me into having treatment that I was uncomfortable with. She answered all my questions. She's the best doctor I have ever been to.

Dec 2022

•

Verified SHC Patient

Dr. Ganjoo was very receptive to my concerns and explained everything to me with clarity

Dec 2022

•

Verified SHC Patient

Dr. Ganjoo is very thorough and very personable. I always feel that she listens to everything I have to say.

Nov 2022

•

Verified SHC Patient

Dr. Ganjoo was extremely encouraging, knowledgeable and kind. I was very happy with the information and advice sheâ€™ have to us and the recommendations she will forward to my local oncologist.

Nov 2022

•

Verified SHC Patient

Such a relief to have the best Stanford Team supporting me.

Nov 2022

•

Verified SHC Patient

Dr Ganjoo is always very thorough and explains everything.

Nov 2022

•

Verified SHC Patient

Dr. Ganjoo is so wonderful. She gives us the information that we need, but she is also very personable with us. Thank you Dr. Ganjoo,!

Nov 2022

•

Verified SHC Patient

Love Dr. Ganjoo- Feel very comfortable with her. Sheâ€™s informative, with helpful suggestions, Receptive to my questions and concerns-

Nov 2022

•

Verified SHC Patient

She's the BEST!

Nov 2022

•

Verified SHC Patient

Dr. Ganjoo is extremely knowledgeable and approachable and appears to be a caring and empathetic.

Nov 2022

•

Verified SHC Patient

Great Doctor.

Nov 2022

•

Verified SHC Patient

I really like Dr. Ganjoo and she works well with my local oncologist. It is great to get the benefits of a specialist in my type of tumor without having to drive all the way to Palo Alto.

Nov 2022

•

Verified SHC Patient

I was very pleased with my virtual appointment with Kristen Ganjoo. She was thorough and kind. Explained everything clearly and answered all of our concerns. It is extremely overwhelming to be dealing with Cancer but she made us feel at ease. We appreciate her taking a few moments to look at my case! What a blessing.

Nov 2022

•

Verified SHC Patient

More than everyone having good "skill sets", everyone showed they cared

Nov 2022

•

Verified SHC Patient

Dr. Ganjoo is a wonderful, expert, caring doctor.

Nov 2022

•

Verified SHC Patient

I believe Dr Ganjoo is a superb Dr. she is the best of many Doctors on my care team

Nov 2022

•

Verified SHC Patient

Iâ€™m blessed to have Dr. Ganjoo on my Care Team

Nov 2022

•

Verified SHC Patient

She is the best of the best and particularly kind and informative.

Oct 2022

•

Verified SHC Patient

She is very clear, attentive and excellent with her care recommendations!

Oct 2022

•

Verified SHC Patient

Incredible doctor and amazing, warm, caring

Oct 2022

•

Verified SHC Patient

excellent care, couldn't be taken care of any better.

Oct 2022

•

Verified SHC Patient

I am.very please with my stay at the hospital. Expect for the services social worker patty provided.

Oct 2022

•

Verified SHC Patient

Great, as usual.

Oct 2022

•

Verified SHC Patient

Awesome doctor!

Sep 2022

•

Verified SHC Patient

Once the video mechanics were up and running, interacting with Kristen Ganjoo was a joy. She provided clear perspectives on my case as well as the scenarios for treatment going forward. I feel very confident and thankful to be under her care.

Sep 2022

•

Verified SHC Patient

She is the best

Sep 2022

•

Verified SHC Patient

very caring and helpful

Sep 2022

•

Verified SHC Patient

She is the best. 10 years of walking me through my recovery. Always pleasant and explained next steps clearly. I thank God for her

Sep 2022

•

Verified SHC Patient

Sheâ€™ll an excellent doctor. I feel safe and comfortable in her care. I trust her expertise implicitly. I highly recommend her as a doctor.

Sep 2022

•

Verified SHC Patient

Dr Ganjoo is a very knowledgeable and is very compassionate Doctor. I have very high regard for her .

Sep 2022

•

Verified SHC Patient

Thanks

Sep 2022

•

Verified SHC Patient

I appreciate her expertise and help.

Sep 2022

•

Verified SHC Patient

Very thorough and I feel confident being under her care.

Sep 2022

•

Verified SHC Patient

Best hospital experience ever!!!

Sep 2022

•

Verified SHC Patient

I think Kristen Ganjoo is an exceptional doctor and a very knowledgeable and kind person. I am here today because of her excellent care. I am so grateful that my doctor referred me to her. She is so thorough and has created an atmosphere of hope and wellness. I feel very fortunate to have her as my doctor.

Sep 2022

•

Verified SHC Patient

Dr Ganjoo is highly intelligent and has a comforting bedside manner. Iâ€™m pleased with my appointment in every way.

Sep 2022

•

Verified SHC Patient

She is very good at her job She makes me feel like I am her only patient .

Sep 2022

•

Verified SHC Patient

Thank you for answering our questions at this point in my cancer journey.

Aug 2022

•

Verified SHC Patient

She explains things very well and she is so knowledgeable & helpful. Sheâ€™s super awesome to work with and she cares about her patients.

Aug 2022

•

Verified SHC Patient

Clear concise straight forward; very open to discussion & explanations

Aug 2022

•

Verified SHC Patient

Doctor Ganjoo is the most caring doctor in my entire treatment

Aug 2022

•

Verified SHC Patient

Dr. Kristen Ganjoo is amazing!!! She has basically saved my life through a mixture of chemotherapy, immunotherapy, and--primarily--recommending me for HIPEC surgery. I had cancer cells splashed randomly around my abdominal walls, and the HIPEC procedure, done after a more traditional tumor resection, looks like it's gotten rid of all the cancer. Over a year later, I'm still in remission, and I credit Dr. Ganjoo's knowledge of the field and available treatments, her aggressive approach to treatment (at least in my case), and her caring and compassion. In my experience, it's extremely rare to find a doctor who is knowledgeable and competent AND compassionate and caring. Usually it's one or the other, but I'm so grateful that in Dr. Ganjoo's case, she combines all of these qualities. I feel extremely lucky and grateful to have her as my oncologist.

Aug 2022

•

Verified SHC Patient

Dr Ganjoo is excellent and explains everything well. I have full confidence in her expertise and care.

Jul 2022

•

Verified SHC Patient

Excellent doctor. Very successful appointment. Provided a clear treatment plan.

Jul 2022

•

Verified SHC Patient

My first meeting with Dr. Ganjoo was excellent. She explained my issues very clearly, and I felt that I was in good hands!

Jul 2022

•

Verified SHC Patient

Thank you Dr. Ganjoo and your team for all you do to keep me healthy.

Jul 2022

•

Verified SHC Patient

Dr. Ganjoo is wonderful. She is helping me navigate through a very complicated medical situation and I am so grateful.

Jul 2022

•

Verified SHC Patient

Dr.Ganjoo is a great doctor.

Jul 2022

•

Verified SHC Patient

Sheâ€™s an awesome Dr and I appreciate the time she takes with me.

Jul 2022

•

Verified SHC Patient

Thank you for being an amazing doctor ! I appreciate you !

Jul 2022

•

Verified SHC Patient

Interested, positive, compassionate! A genuine pleasure.

Jul 2022

•

Verified SHC Patient

Very pleased with the follow up and information I have received from Dr. Ganjoo.

Jul 2022

•

Verified SHC Patient

We are very pleased to have Dr. Ganjoo as my mother's oncologist. She is warm, friendly, empathic and extremely knowledgable. We know she cares about all aspects of mom's life.

Jul 2022

•

Verified SHC Patient

Dr. Ganjoo shows she care about my health issue, answered all my question and being very patient. A nice and knowledgeable doctor to work with.

Jul 2022

•

Verified SHC Patient

She's an excellent and caring physician and I would recommend her highly.

Jul 2022

•

Verified SHC Patient

She's great. Thinking ahead about ways to avoid/detect any future cancers. A great relief to have her on my team.

Jul 2022

•

Verified SHC Patient

Thank God for Dr. Ganjoo. I canâ€™t thank her enough for saving my life. She was able to line my surgery up in a speedy timeline. Her team of surgeons were excellent. I met them several times after the surgery. So skilled, so personable! I am thrilled about my outcome.

Jul 2022

•

Verified SHC Patient

Dr. Ganjoo is wonderful, empathetic and immediately put me at ease.

Jul 2022

•

Verified SHC Patient

A wonderful doctor to work with

Jun 2022

•

Verified SHC Patient

Dr. Ganjoo has a calm and compassionate demeanor that really helps put me at ease during these visits. I have total confidence in her recommendations for my treatment. I am so happy and relieved to have her on my care team!

Jun 2022

•

Verified SHC Patient

Itâ€™s a pleasure talking to dr Ganjoo. She always has some fresh insights into the problem that my mom is dealing with. She is extremely knowledgeable in her domain of expertise. Itâ€™s talking to her that keeps giving up hope that we some chance of dealing with the problem we are facing.

Jun 2022

•

Verified SHC Patient

Very pleasant Doctor with wonderful bedside manners. I am so thankfulâ ¤ï¸

Jun 2022

•

Verified SHC Patient

Dr. Ganjoo is a wonderful doctor and listened very closely to all of my concerns. She was very respectful and remembered things we had discussed two months ago from our very first video conference. I am very thankful to have her as my doctor.

Jun 2022

•

Verified SHC Patient

I am extremely happy with the care I have received from Dr Ganjoo and her colleges at Stanford

Jun 2022

•

Verified SHC Patient

Very informative, listened to my concerns.

Jun 2022

•

Verified SHC Patient

As I have communicated with my surgeon and his PA, virtually everyone I encountered was professional and, most reassuring to a person facing major surgery for the first time ever, empathetic.

May 2022

•

Verified SHC Patient

Thank you Dr. Ganjoo for listening and always hearing and checking into the issues and challenges I bring up. I really appreciate you open and objective support.

May 2022

•

Verified SHC Patient

Explained future possible care for the future if needed.

May 2022

•

Verified SHC Patient

Dr. Ganjoo is always friendly, caring and informative when we meet. I have a very high level of confidence in Dr. Ganjoo and her expertise in following my sarcoma post surgical care. I feel Dr. Ganjoo is extremely thorough which I very much appreciate.

May 2022

•

Verified SHC Patient

Dr. Ganjoo is clearly the best oncologist in California.

May 2022

•

Verified SHC Patient

Dr. Ganjoo is very competent, methodical and caring. My mother has been dealing with some pain issues and we have been searching for answers to no avail. She has been getting progressively worse, and we have not had a good response from any of her doctor visits until today with Dr. Ganjoo. In 25 minutes, Dr. Ganjoo identified several possibilities that may be causing the pain, adjusted medications to those that would not further exasperate my mother's condition, and ordered a PET scan asap to determine the cause of the pain. It was a nice change after having been offered no explanation or diagnosis for over 6 weeks.

May 2022

•

Verified SHC Patient

Dr. Ganjoo is great!

May 2022

•

Verified SHC Patient

It was over all very good but when I asked the nurse when I was in the care unit why they were giving certain medications I didnâ€™t get answers.

May 2022

•

Verified SHC Patient

Thanks again Kristen for your help.

May 2022

•

Verified SHC Patient

Excellent facility and staff. All that I expected Stanford to be like!!!!

May 2022

•

Verified SHC Patient

Dr Gangoo is a fantastic health care provider

May 2022

•

Verified SHC Patient

Caring kind very knowledgeable and proactive

May 2022

•

Verified SHC Patient

I felt comfortable, felt she cared about me an my treatment. She has a treatment plan which is very comforting.

May 2022

•

Verified SHC Patient

She is so professional and right to the point. You are put at ease as she goes through your medical history and is very straight forward about how she feels she should proceed with your care. I would recommend her to anyone that had sarcoma.

Apr 2022

•

Verified SHC Patient

She went above and beyond, so grateful

Apr 2022

•

Verified SHC Patient

Expert in her field. Very compassionate. Very patient answering all questions.

Apr 2022

•

Verified SHC Patient

good visit.

Apr 2022

•

Verified SHC Patient

Thank you, Dr. Ganjoo!

Apr 2022

•

Verified SHC Patient

Dr. Ganjoo is very nice and helpful. Really appreciate her help.

Apr 2022

•

Verified SHC Patient

Doctoc Ganjoo answered all questions and provided excellent explanations. Thanks a lot!

Mar 2022

•

Verified SHC Patient

She was very friendly and seemed to have a good grasp of what I am dealing with. She also provided me an option to join a clinical trial that was never an option for me before. I liked her.

Mar 2022

•

Verified SHC Patient

Dr. Ganjoo is as excellent a communicator and as pleasant online as is person. I feel very fortunate to have her as my physician.

Mar 2022

•

Verified SHC Patient

Dr Ganjoo is wonderful. Her knowledge and care are greatly appreciated.

Mar 2022

•

Verified SHC Patient

All my questions were answered and the plan after my surgery was covered too. I know what to expect and anticipate going forward for treatment.

Mar 2022

•

Verified SHC Patient

Happy to reconnect with Dr Ganjoo

Mar 2022

•

Verified SHC Patient

Sheâ€™s a very caring and excellent doctor that listens

Mar 2022

•

Verified SHC Patient

Very knowledgeable, personable and helpful. As a patient, I am SO appreciative that she will be on my team as a patient going forward!

Mar 2022

•

Verified SHC Patient

THANK YOU I couldn't be happier knowing I have a great Dr like you

Mar 2022

•

Verified SHC Patient

She was great. She explained everything in detail and answered all my questions.

Mar 2022

•

Verified SHC Patient

Thank you, Dr. Ganjoo, for patiently answering my questions and offering kindness and encouragement.

Mar 2022

•

Verified SHC Patient

I truly respect Dr Ganjoo. She is compassionate, knowledgeable and vested in doing what is right for each of her patients. I know that she has a very heavy workload and she never makes it appear as though she doesnâ€™t have enough time for me. I appreciate her care very much and feel very fortunate to be able to call her my doctor.

Mar 2022

•

Verified SHC Patient

Excellent doctor.

Mar 2022

•

Verified SHC Patient

Sheâ€™s the best

Mar 2022

•

Verified SHC Patient

Dr. Ganjoo is a fantastic physician and I would recommend her to anyone. She listens intently to what I have to say, she is always extremely kind and empathetic, and I feel that she is concerned about my fears and my care. I appreciate her so much.

Mar 2022

•

Verified SHC Patient

Their was very attentive and caring.

Mar 2022

•

Verified SHC Patient

She is excellent and I am grateful she is my oncologist.

Feb 2022

•

Verified SHC Patient

Dr. Ganjoo answered all of my questions and have given me tremendous support over the last 6 months while treating my desmoid tumor. Iâ€™m very grateful to have her as my doctor!

Feb 2022

•

Verified SHC Patient

Dr. Ganjoo was very knowledgeable and provided details on what needed to be done.

Feb 2022

•

Verified SHC Patient

I could not be happier with the care I have received from Dr. Ganjoo.

Feb 2022

•

Verified SHC Patient

Very clear and thorough. Always has options

Feb 2022

•

Verified SHC Patient

Dr. Ganjoo has been wonderful! She is very easy to talk to and understand on our video visits. I do hope that someday I can meet her in person, however the video visits have been super as I live in Sacramento.

Feb 2022

•

Verified SHC Patient

Excellent Physician, informative, courteous, compassionate and answered all questions & concerns.

Feb 2022

•

Verified SHC Patient

Doctor Ganjoo is wonderful. Dr Visser and all of my doctors at Stanford have been wonderful.

Feb 2022

•

Verified SHC Patient

Dr Ganjoo communicates information in understandable terms....sometimes anticipating my questions.

Jan 2022

•

Verified SHC Patient

Dr. Kristen Ganjoo is very approachable, and I have felt at ease in all my appointments with her. Even with my condition she has made me feel hopeful and not give up. That is so important for all patients.

Jan 2022

•

Verified SHC Patient

Compassionate, direct, experienced, supportive, cutting edge, perfect fit for me.

Jan 2022

•

Verified SHC Patient

Dr Ganjoo was great! Very nice and answered all my questions.

Jan 2022

•

Verified SHC Patient

Iâ€™m grateful to have Dr. Ganjoo as part of my care team

Jan 2022

•

Verified SHC Patient

Sheâ€™s a great Dr. She answers all your questions and never rushs you. Sheâ€™s very friendly and makes you feel well taken care of even in a hard medical situation.

Jan 2022

•

Verified SHC Patient

Very helpful, knowledgeable, and pleasant to talk to. Answered all of my questions throughly. I feel confident with her in charge of my care.

Jan 2022

•

Verified SHC Patient

Dr. Ganjoo is wonderful! She is extremely knowledgeable, listens well and takes into considerations my thoughts and feelings on treatment. I consider myself very lucky to be treated by Dr. Ganjoo.

Jan 2022

•

Verified SHC Patient

Good Meeting

Jan 2022

•

Verified SHC Patient

Very good communicator

Jan 2022

•

Verified SHC Patient

Dr. Ganjoo is excellent.

Jan 2022

•

Verified SHC Patient

Dr. Ganjo is an excellent doctor with good experience and presentation.

Jan 2022

•

Verified SHC Patient

Excellent doctor, but very very busy.

Jan 2022

•

Verified SHC Patient

Dr. Ganjoo is great doctor who explains everything and is very helpful and understanding. She is an amazing doctor.

Jan 2022

•

Verified SHC Patient

Dr. Ganjoo presentation of information was excellent. She was respectful and kind during the entire visit. She offered information that was insightful and she helped us to better understand the condition of our mother's leg cancer and treatment options. She is an excellent physician educator. Please extend our thanks to Dr. Ganjoo and her team.

Jan 2022

•

Verified SHC Patient

Thank you Dr. Ganjoo!

Jan 2022

•

Verified SHC Patient

Wonderful

Dec 2021

•

Verified SHC Patient

Dr. Ganjoo is very helpful. She listened to my concerns and answer all my questions. It's a pleasure to have Dr. Ganjoo as my oncologist at this difficult time for me.

Dec 2021

•

Verified SHC Patient

I am definitely recommend this doctor to my friends. She is highly professional, taking as much time, as you need and a pleasant and caring person.

Dec 2021

•

Verified SHC Patient

The surgeons and their respective surgeries were terrific...

Dec 2021

•

Verified SHC Patient

Excellent consultation. Dr. Ganjoo was very courteous, pleasant & professional.

Dec 2021

•

Verified SHC Patient

Dr. Ganjoo is awesome. She made me feel good and she was confident in her diagnosis treatments. Her people skills were very warm and welcoming. She answered every question and was proud of her statistics in treating my cancer!

Dec 2021

•

Verified SHC Patient

Professional, respectful, passionate, caring

Dec 2021

•

Verified SHC Patient

Really appreciate Dr. Ganjoo's help. She is very sincere, thoughtful, and genuinely cares about patients.

Dec 2021

•

Verified SHC Patient

Excellent

Dec 2021

•

Verified SHC Patient

She was wonderful and I felt so much better after talking with her. I feel confident I have a great plan going forward now and a great doctor. Thank you.

Dec 2021

•

Verified SHC Patient

Dr. Ganjoo takes time to explain any questions that you have. I so thankful for someone who knew exactly what is going on with me and have a treatment plan.

Dec 2021

•

Verified SHC Patient

Thank you Dr. Ganjoo for taking care of my health. Wish you a safe and wonderful holidays!

Dec 2021

•

Verified SHC Patient

She is incredibly knowledgeable and an excellent communicator

Dec 2021

•

Verified SHC Patient

She explain everything very well and we ask questions and she answer the questions I got a good information more or less what weâ€™re gonna do I want to thank you Dr. could you for explain to me whatâ€™s going on with my body and with the cancer thank you very much

Dec 2021

•

Verified SHC Patient

Very nice and very easy to explain that I understand her

Nov 2021

•

Verified SHC Patient

Dr. Kristen Ganjoo is an excellent , highly professional specialist and a person With warm heart. She cares about her patients and is trying to help in any possible way. Thank you Dr. Ganjoo!

Nov 2021

•

Verified SHC Patient

Extremely helpful and knowledgeable. Looking forward to working with her to address my health issues.

Nov 2021

•

Verified SHC Patient

My daughter and I find Dr Ganjoo gives us information that we need.

Nov 2021

•

Verified SHC Patient

Thank you Kristen.

Nov 2021

•

Verified SHC Patient

Dr. Ganjoo listens to what I have to say and thoroughly reviews test results with me. She is very patient and I feel very confident that she cares about my health.

Nov 2021

•

Verified SHC Patient

She is a great doctor and takes great care of me and always concerned about my health .

Nov 2021

•

Verified SHC Patient

Very prepared with well thought out next steps

Nov 2021

•

Verified SHC Patient

Thank you

Oct 2021

•

Verified SHC Patient

I have a lot of confidence in Dr. Ganjoo. Trust is certain.

Oct 2021

•

Verified SHC Patient

Dr. Ganjoo is awesome canâ€™t say it enough.

Oct 2021

•

Verified SHC Patient

My experience was very good. I felt well cared for.

Oct 2021

•

Verified SHC Patient

She is a great clinician and technically quite able. No communication problems

Oct 2021

•

Verified SHC Patient

Dr. Ganjoo is amazing and I am so happy to have her as my oncologist. She made me feel very comfortable and I felt her genuine compassion. I liked how she made sure to go through every detail, and she already had a plan in place by the time we ended our call. The sense of urgency was there.

Oct 2021

•

Verified SHC Patient

Dr. Ganjoo is an incredible doctor and individual. She is caring and very professional.

Oct 2021

•

Verified SHC Patient

Quick less than 15 minute appointment. Amiable doctor. Wish there was more time for discussion of side effects and things to expect in coming weeks. Pain and management of side effects needed to be discussed but we ran out of time. Also she did not mention how my next appointment would be set up.

Oct 2021

•

Verified SHC Patient

Dr. Ganjoo is generous with her time and communicates well.

Oct 2021

•

Verified SHC Patient

She is amazing. A cut above.

Oct 2021

•

Verified SHC Patient

She is the best Dr thanks Dr Ganjoo

Oct 2021

•

Verified SHC Patient

She is an expert in her field, knowledgeable and informed. She is also kind, and the well being of her patients is most important to her. Dr. Ganjoo welcomes questions and is articulate, kind, and thorough as she explains things. She is an excellent doctor.

Sep 2021

•

Verified SHC Patient

So pleasant and easy to talk to. She listens carefully and answers All our questions. Does not make us feel rushed at all. Couldnâ€™t be better.

Sep 2021

•

Verified SHC Patient

Very positive conversation Knowledgeable, but able to communicate clearly. Impressed she will follow up with my Kaiser oncologist

Sep 2021

•

Verified SHC Patient

I love Dr. Ganjoo! She was very thorough with her questions and discussion about my condition specific to the visit but also my health in general as I have other unrelated heath conditions. She spent the appropriate time and was not rushed. I appreciated the time spent with Dr. Ganjoo.

Sep 2021

•

Verified SHC Patient

Very happy with Dr. Ganjoo.

Sep 2021

•

Verified SHC Patient

Thank you Dr. Ganjoo. See my comments in the last window. That was a very easy an enjoyable video conference. I look forward to working with you and your team.

Sep 2021

•

Verified SHC Patient

Excellent

Sep 2021

•

Verified SHC Patient

I Answered this on prior page. Dr Ganjoo is great. Calm and peaceful. Thanks

Sep 2021

•

Verified SHC Patient

Dr Ganjoo answers questions understandably and gives information in clear terms.

Sep 2021

•

Verified SHC Patient

Dr Ganjoo is simply the best. She is extremely knowledgeable in her area of expertise, very empathetic and responsive. I am extremely fortunate to have her guiding my care team.

Sep 2021

•

Verified SHC Patient

I am very pleased with all the care I have received at Stanford, including Dr. Ganjoo.

Sep 2021

•

Verified SHC Patient

Dr. Ganjoo is very patience and knowledgeable, she was able to provide me with lots of helpful information.

Sep 2021

•

Verified SHC Patient

Excellent, welcoming warm manner. Explained everything very clearly. She is very impressive. Listens carefully.

Sep 2021

•

Verified SHC Patient

Friendly, easy to converse with, covers the necessary basis needed.

Sep 2021

•

Verified SHC Patient

I am so grateful for Dr Ganjoo, she always helps me with my medical issues by answering questions, providing referrals etc. Always putting me at ease.

Sep 2021

•

Verified SHC Patient

What a lovely lady! She had gone through my notes and had questions for me which I truly appreciate - she seemed to be fully up to speed on my case

Sep 2021

•

Verified SHC Patient

Excellent

Sep 2021

•

Verified SHC Patient

Kristen is by far one of the best doctors I have seen. She is thorough, positive, and extremely knowledgeable about my condition. She always gets back to me when I have questions as well.

Sep 2021

•

Verified SHC Patient

I look forward to seeing her in October

Aug 2021

•

Verified SHC Patient

I love how she takes the time to review notes and explain things clearly to me. I always finish the appointment understanding my cancer and options better.

Aug 2021

•

Verified SHC Patient

Dr. Ganjoo is the best!

Aug 2021

•

Verified SHC Patient

She is an excellent doctor, wonderful human bring who is compassionate about her work & her patients. Iâ€™m a doctor myself & dealing with my rare GIST cancer, Dr Ganjoo has been the most concerned, understanding, helpful Oncologist that Iâ€™ve had during my 22 years dealing with this disease. Very little is known about diagnosis, treatment or cure agents for GIST. Dr Ganjoo listens to me & respects my judgement while injecting her knowledge into the various procedures & treatment plans. Sheâ€™s up-to-date on most of the latest treatment modalities & procedures. Her knowledge of GIST far exceeds any other Stanford doctors Iâ€™ve had in the past. I havenâ€™t been happy with any of my Stanford doctors except Dr Ganjoo & the famous Dr So (Liver Surgeon who preformed my left lobectomy).

Aug 2021

•

Verified SHC Patient

Dr. Ganjoo was very helpful, she explained everything thoroughly. Very kind and personable.

Aug 2021

•

Verified SHC Patient

Dr Ganjoo is a wonderful and is very knowledgeable in my health and treatment. She leaves me feeling comfortable and hopeful that that my systems will be better.

Aug 2021

•

Verified SHC Patient

She is really nice and caring.

Aug 2021

•

Verified SHC Patient

Communication was very good,

Aug 2021

•

Verified SHC Patient

Very informative. Glad to have her as my physician.

Aug 2021

•

Verified SHC Patient

I always feel like Dr. Ganjoo is very thorough and answers any questions I have, and clarifies any information I was uncertain about.

Aug 2021

•

Verified SHC Patient

Doctor is outstanding

Aug 2021

•

Verified SHC Patient

Dr. Ganjoo is an excellent practitioner.

Aug 2021

•

Verified SHC Patient

Excellent

Aug 2021

•

Verified SHC Patient

Dr Ganjoo had made a terrifying situation comforting and promising with a positive outlook

Jul 2021

•

Verified SHC Patient

Fantastic, knowledgeable, kind, empathetic doctor who listened well to me (Patient). Would recommend her to anyone with this condition and feel so much better knowing she is on my team.

Jul 2021

•

Verified SHC Patient

She was very helpful

Jul 2021

•

Verified SHC Patient

I enjoyed talking with her and Dr. Joseph Cleveland regarding my medical issues. they seemed well acquainted with my medical history and had a positive outlook which made me feel so much better. I look forward to having her participate in my care.

Jul 2021

•

Verified SHC Patient

Kristen Ganjoo is an amazing doctor who provided life saving treatment to me for the past few years. She is extremely professional and kind.

Jul 2021

•

Verified SHC Patient

She is very through and compassionate. She listens and answers my questions throughly. Dr Ganjoo responded very quickly to my request for a dermatologist. I was called soon after my appointment with her. I really appreciate the care I am getting from her.

Jul 2021

•

Verified SHC Patient

Best doctor ever!

Jul 2021

•

Verified SHC Patient

Dr Ganjoo is excellent!

Jul 2021

•

Verified SHC Patient

Excellent doctor and very friendly.

Jun 2021

•

Verified SHC Patient

Excellent

Jun 2021

•

Verified SHC Patient

I am grateful to be in Dr. Ganjoo's care.

Jun 2021

•

Verified SHC Patient

A big thank you to Dr Ganjoo for her time, support and information. My partner and I had lots of questions, and she answered every single question and provided a plan that we can now follow and understand.

Jun 2021

•

Verified SHC Patient

Dr. Ganjoo is an amazing doctor and exceptional human being. Her excellent care and caring heart has helped to heal my mother. Please recognize the enormous value Dr. Ganjoo brings to Stanfordâ€™ Health care. We are forever grateful and appreciative to Dr. Ganjoo.

Jun 2021

•

Verified SHC Patient

Dr. Ganjoo is an excellent health provider. She is very thorough and attentive.

Jun 2021

•

Verified SHC Patient

Dr. Ganjoo is a beacon of specialty and expertise in my particular type of cancer. I appreciate her insight very much (virtual or in person.)

Jun 2021

•

Verified SHC Patient

Dr. Ganjoo is exceptional. I can't begin to express the gratitude I have for having her on my care team.

Jun 2021

•

Verified SHC Patient

Dr Ganjoo made me comfortable during my first video appointment.

Jun 2021

•

Verified SHC Patient

Thank you for your clear and concise explanations of all factors associated with my leiomyosarcoma as well as my surgery. I appreciate your cheerful, upbeat demeanor too.

May 2021

•

Verified SHC Patient

Excellent Doctor She saves my life

May 2021

•

Verified SHC Patient

Very informative and listens to my concerns

May 2021

•

Verified SHC Patient

I can't say enough good about Dr. Ganjoo. As I said, I can't imagine going through this without her. She knows me and how I feel about things, treatments and such. She's always answers my questions honestly and fully, taking time to make sure I understand. I have a weird sense of humor and just because I have cancer doesn't keep me from joking about the ins and outs of it. I just feel like she gets me, gets us. My husband feels the same way. I've been blessed throughout this whole process, I mean cancer is just huge and I've chosen a way through it with the usual chemo and radiation. Dr. Ganjoo has never made me feel 'less than', has always been helpful and honest. She's always professional but she cares. I guess that's really it. She cares, and it shows. She's the best there is and she represents Stanford well. You can only be as good as the people who represent you...she's awesome.

May 2021

•

Verified SHC Patient

Excellent. It is great to have a specialist in my relatively uncommon tumor. She has always been friendly and extremely helpful. Thank you.

May 2021

•

Verified SHC Patient

Dr Ganjoo is a wonderful doctor, and although I am not happy that I have leiomyosarcoma, I am happy that I am in excellent care under her. She is understanding, compassionate, interested in my life as a whole, responds quickly, answers all my questions, and works seamlessly with the oncologists at my local cancer center from where I am receiving treatment under Dr. Ganjoo's expert leadership and guidance. I am so grateful that Stanford has video visit capabilities so that I can see Dr. Ganjoo despite living four hours away.

May 2021

•

Verified SHC Patient

Dr. Ganjoo is very caring and we always feel she has my best interests at heart. She has been working hard with me to find the right treatments. She is always open to listen to my concerns and questions and provide her expertise.

May 2021

•

Verified SHC Patient

I truly enjoyed talking to Dr. Ganjoo. She was very kind and thorough.

May 2021

•

Verified SHC Patient

Dr. Ganjoo was very thorough with her explanation of my problem. She was also very calming and reassuring.

May 2021

•

Verified SHC Patient

Outstanding and caring.

May 2021

•

Verified SHC Patient

I have been under the care of Dr. Ganjoo for just over a year. She is a true professional in every sense of the word. Outstanding guidance, recommendations and support. I was very fortunate to have Dr. Ganjoo care for me.

Apr 2021

•

Verified SHC Patient

One of the most positive doctor/patient interactions in my experience.

Apr 2021

•

Verified SHC Patient

She is very caring kind & has a lot of concern & compassion for her patients.

Apr 2021

•

Verified SHC Patient

Very happy to have her as my doctor.

Apr 2021

•

Verified SHC Patient

Dr Ganjoo has always been very comforting and approachable. I feel so fortunate to be in her care.

Apr 2021

•

Verified SHC Patient

Dr. Ganjoo is knowledgeable and courteous and personable.

Nov 2020

•

Verified SHC Patient

Dr. Ganjoo & her NP were exactly the ppl. we needed to see at the exact right time. My husband just received troubling news about his cancer reoccurrence & your staff/MDs spoke with authority, confidence & compassion in telling us it would be alright! We are overjoyed & filled with gratitude that we were able to see these health care providers.

Sep 2020

•

Verified SHC Patient

All the time very good.

Jul 2020

•

Verified SHC Patient

She is very knowledgeable, she takes time to listen to our concern.

Apr 2020

•

Verified SHC Patient

Very professional.

Apr 2020

•

Verified SHC Patient

Dr. Ganjoo & her team are highly competent for guidance of my illness.

Apr 2020

•

Verified SHC Patient

Dr. Ganjoo is the best!

Feb 2020

•

Verified SHC Patient

Excellent!

Feb 2020

•

Verified SHC Patient

Covered all questions & concerns I had.

Jan 2020

•

Verified SHC Patient

I have already recommended this provider to others with same diagnosis.

Jan 2020

•

Verified SHC Patient

Dr. Ganjoo and her staff were amazing. I would highly recommend them.

Jan 2020

•

Verified SHC Patient

It was my first time having surgery anywhere and the doctors and staff/nurses were wonderful.

Jan 2020

•

Verified SHC Patient

Very well information and instructions the care provider gave me about follow up care.

Jan 2020

•

Verified SHC Patient

Dr. Ganjoo demonstrates her knowledge & compassion of my cancer & me in the most comfortable & confidence inspiring ways. I know I am in good hands.

Dec 2019

•

Verified SHC Patient

All good.

Dec 2019

•

Verified SHC Patient

I have been seeing Dr. Ganjoo for 9 years. She is an empathetic doctor who listens to my concerns; looks up info related to my meds, treatment. Having her as my sarcoma doctor has been a very positive experience in this chronic cancer journey I am traveling!

Dec 2019

•

Verified SHC Patient

Dr. Tanya Gupta & Dr. Kristen Ganjoo are exceptional - clear, thorough. Compassionate, responsive and left me feeling completely confidence in their care & advice!

Oct 2019

•

Verified SHC Patient

Have already recommended to follow angio sarcoma patients. so reassuring to see MD that is familiar with rare cancer type -

Oct 2019

•

Verified SHC Patient

Dr. Ganjoo is kind, professional, expert, and caring!

Sep 2019

•

Verified SHC Patient

Dr. Ganjoo is the finest medical practitioner with whom I ever encountered. She had saved my life.

Sep 2019

•

Verified SHC Patient

Dr. Ganjoo explains procedures/treatment extremely well.

Sep 2019

•

Verified SHC Patient

Outstanding professionals.

Aug 2019

•

Verified SHC Patient

Dr. Raffi Avedian is a very special human being -

Jul 2019

•

Verified SHC Patient

Dr. Ganjoo is great!

Jun 2019

•

Verified SHC Patient

Never felt rushed or that any question was too small.

Jun 2019

•

Verified SHC Patient

Was very impressed by their care & attention they gave me. Thank you!

Apr 2019

•

Verified SHC Patient

Dr. Ganjoo has been an amazing care provider since 2011.

Apr 2019

•

Verified SHC Patient

Dr. Ganjoo is the most amazing doctor I have ever met. Not only is she a great physician, but she has the perfect personality too.

Apr 2019

•

Verified SHC Patient

Dr. Ganjoo has treated me for almost 10 years. Without her care, I'm not sure I'd be here today. Her kindness, knowledge, and humor have helped me in so many beneficial ways. I look forward to our next visit.

Apr 2019

•

Verified SHC Patient

Dr. Ganjoo provides the BEST care experience I could ask for. She genuinely cares about my health and treatment and does so on a personal level.

Dec 2018

•

Verified SHC Patient

Everyone showed that they were concerned about my health.

Dec 2018

•

Verified SHC Patient

Dr. Ganjoo said she would recommend certain blood tests to my local oncologist. I've sent 2 myhealth emails and it hasn't happened that I know about.

Nov 2018

•

Verified SHC Patient

Fantastic surgeon is every possible aspect!

Nov 2018

•

Verified SHC Patient

Dr. Ganjoo is very excellent. I only wish the testing could move faster, not her fault.

Sep 2018

•

Verified SHC Patient

Dr. Ganjoo is amazing. I am fortunate to be in remission for 2 years. I am still scared and she takes excellent care of me, both physically and emotionally.

Sep 2018

•

Verified SHC Patient

Dr. Ganjoo Kristen Nooshin, MD one of the best doctors I have met. She cares about her patients.

Sep 2018

•

Verified SHC Patient

First time very good.

Aug 2018

•

Verified SHC Patient

Dr. Kristen Ganjoo is an A+ Doctor! Too the time to explain everything to me.

Aug 2018

•

Verified SHC Patient

Dr. Ganjoo is an excellent & understanding doctor one of the best dr. that I've seen.

Jul 2018

•

Verified SHC Patient

The Stanford staff members I deal with are all first rate.

Jul 2018

•

Verified SHC Patient

Dr. Ganjoo is great! I am so thankful we found her & I am her patient. She is so easy to talk with & she listens. My cancer is in remission.

Jun 2018

•

Verified SHC Patient

I am in the best hands possible and that comforts not only me, but my family as well

May 2018

•

Verified SHC Patient

I can't say enough about the level of concern and caring given by every single person we met or talked with while there.

May 2018

•

Verified SHC Patient

A+ treatment.

May 2018

•

Verified SHC Patient

Dr. Ganjoo resolved a problem/confusion about who we were supposed to see. She called another doctor and got us an appointment right away. I really liked how she took into account how far we'd come & the hardship of having to come back & the anxiety of more waiting to be seen.

May 2018

•

Verified SHC Patient

Dr. Ganjoo is very personable and a pleasure to deal with.

Apr 2018

•

Verified SHC Patient

Dr. Ganjoo = excellent clinician. Thanks!

Apr 2018

•

Verified SHC Patient

Very personable on this visit.

Apr 2018

•

Verified SHC Patient

We have seen Dr. Ganjoo many times now. She is friendly and communicates on levels both I and my wife (who is an RN) can understand.

Apr 2018

•

Verified SHC Patient

I came from Hawaii for this appointment and spent 3 hours. It was very informative and well worth the trip.

Mar 2018

•

Verified SHC Patient

I always get the best care and follow-up from Dr. Ganjoo and staff!

Feb 2018

•

Verified SHC Patient

Overall, a very positive meeting. Took all the time we needed.

Feb 2018

•

Verified SHC Patient

Dr. Ganjoo is very knowledgeable, professional, respectful and kind. She is quick to respond to health issues and immediately is proactive in obtaining results.

Feb 2018

•

Verified SHC Patient

I feel very confident Dr. Ganjoo is looking out for my health!

Jan 2018

•

Verified SHC Patient

Good -

Jan 2018

•

Verified SHC Patient

I AM VERY HAPPY WITH DR. GANJOO AND SO SATISFIED THAT I AM AT THE RIGHT PLACE. WISH I WAS HERE YEARS EARLIER.

Jan 2018

•

Verified SHC Patient

Dr. Ganjoo is very personable.

Dec 2017

•

Verified SHC Patient

Dr Ganjoo was wonderful, spent time answering my questions, plus gave me a very thorough explanation of care plan & medications.

Dec 2017

•

Verified SHC Patient

Superb.

Nov 2017

•

Verified SHC Patient

I love my provider and her NP Ruth Caldron! They are amazing.

Oct 2017

•

Verified SHC Patient

Dr. Ganjoo is awesome. She is great to work with and always very pleasant.

Oct 2017

•

Verified SHC Patient

After that visit, I will be switching to this provider for my ongoing care.

Oct 2017

•

Verified SHC Patient

NP and drs. were exceptional.

Sep 2017

•

Verified SHC Patient

Since I went in for the first time I felt good & with much confidence that they had helped me & cured me there. Thanks to God I am much better.

Sep 2017

•

Verified SHC Patient

Dr. Ganjoo was very calming and explained what she thought was going to happen.

Jul 2017

•

Verified SHC Patient

Same as for the nurse above. Excellent doctor! I have already recommended her!

Jul 2017

•

Verified SHC Patient

She was excellent - just poor timing due to emergency drill which certainly was not her fault. I thought she was great!

Jul 2017

•

Verified SHC Patient

Always so grateful for Dr. Ganjoo - her expertise and professionalism.

Jun 2017

•

Verified SHC Patient

Dr. Ganjoo was very kind and accommodating. She showed genuine concern and acted in my father's best interests.

Jun 2017

•

Verified SHC Patient

I love Dr. Ganjoo's staff!

Jun 2017

•

Verified SHC Patient

The doctor provided a very good experience after having a bad experience with my cancer doctor. She explained everything and was very caring.

Jun 2017

•

Verified SHC Patient

Dr. Ganjoo is outstanding.

May 2017

•

Verified SHC Patient

Dr. Ganjoo have been at my side since 2009. She is a kind and skilled doctor that is possibly save my life with her concern and skill. Actually, she has saved my life!

May 2017

•

Verified SHC Patient

Excellent doctor.

Apr 2017

•

Verified SHC Patient

As much as Dr. Ganjoo as her assistant Dr. Evan Hall attended me very well, with courtesy and attentively they explained regarding the Sarcoma.

Apr 2017

•

Verified SHC Patient

All were great.

Apr 2017

•

Verified SHC Patient

Good.

Apr 2017

•

Verified SHC Patient

Dr. Ganjoo prescribed a unique course of chemo and radiation that was highly successful in treating my cancer. Her confidence in the treatment her caring attitude, and her careful explanations were a strong comfort. Excellent doctor.

Apr 2017

•

Verified SHC Patient

This was my last visit w/Dr. Ganjoo - I've been released after 10 yrs. of follow-up appt. She is wonderful and I will miss seeing her very much. She told me to call her immediately if I ever have any symptoms of lymphoma.

Apr 2017

•

Verified SHC Patient

Very pleased with the Care provider.

Apr 2017

•

Verified SHC Patient

Dr. Kristen Ganjoo is excellent - Ruth Calderone is excellent.

Mar 2017

•

Verified SHC Patient

I feel that I am falling through the cracks, since David Miller has left.

Mar 2017

•

Verified SHC Patient

Dr. Ganjoo is exceptional. One of my favorite doctors level of care, concern, expertise in her field.

Mar 2017

•

Verified SHC Patient

I love Dr. Ganjoo!

Feb 2017

•

Verified SHC Patient

Always very good!

Feb 2017

•

Verified SHC Patient

Very confident with Stanford.

Jan 2017

•

Verified SHC Patient

Caring, friendly.

Jan 2017

•

Verified SHC Patient

Both Dr. Ganjoo & Ruth Calderon are always excellent, knowledgeable & friendly.

Dec 2016

•

Verified SHC Patient

Amazing doctor! Well prepared and had a plan in mind before speaking with me. Gave me as much time as I wanted. I only wish she had written it down for me.

Oct 2016

•

Verified SHC Patient

Excellent experience!

Oct 2016

•

Verified SHC Patient

Always the very best medical staff. Never any issues or problems.

Oct 2016

•

Verified SHC Patient

Dr. Ganjoo always shows care & concern and spends time with me. I never feel rushed. Very confident in her care.

Oct 2016

•

Verified SHC Patient

Dr. Kristen N. Ganjoo is an excellent doctor.

Oct 2016

•

Verified SHC Patient

All excellent - explained everything in understandable detail - very personable no issues or problems.

Sep 2016

•

Verified SHC Patient

Wonderful Doctor Ganjoo.

Sep 2016

•

Verified SHC Patient

Both David Miller and Dr. Ganjoo are wonderful to work with. My nurse @ South Bay Center ITA, Cyndy, was also fantastic.

Aug 2016

•

Verified SHC Patient

I love Dr. Norton so much & have complete confidence in his care. I feel so blessed to have been luck enough to have him as my surgeon & dr.

Jul 2016

•

Verified SHC Patient

Dr. Ganjoo is the best doctor that I've ever seen. Very professional & caring about the patient.

Jul 2016

•

Verified SHC Patient

No issues or problems, always professional with a personal touch!

Jul 2016

•

Verified SHC Patient

Dr. Kristen N. Ganjoo is an excellent doctor!

May 2016

•

Verified SHC Patient

Dr. Ganjoo is incredibly patient and helpful. She welcomes questions and always ensures that you understand the information she is sharing. She is forthcoming and incredibly knowledgeable. The work research/trials she has been doing are a God send to me. I am grateful that she is doing some amazing work. Dr. Ganjoo is bright, kind, helpful & amazing.

May 2016

•

Verified SHC Patient

Dr. Ganjoo is great. She does not rush and shows concern and answers questions.

Apr 2016

•

Verified SHC Patient

Dr. Ganjoo took the time necessary to answer all my questions. I was concerned that I might be taking too much of her time, but she never made me feel that way. She was completely focused on my needs and I am grateful to be her patient.

Apr 2016

•

Verified SHC Patient

I thought everyone was very good, especially Dr. Ganjoo.

Apr 2016

•

Verified SHC Patient

Dr. Banjo is wonderful, I always look forward to apps with her.

Mar 2016

•

Verified SHC Patient

Dr. Kristen H Ganjoo is an excellent doctor!

Mar 2016

•

Verified SHC Patient

Dr. Ganjoo so far has been outstanding - - Compassionate, clear, easy to talk to, thorough, listens well & answers very easy to understand -

Mar 2016

•

Verified SHC Patient

Highly professional staff.

Mar 2016

•

Verified SHC Patient

Dr. Kristen Ganjo is the best!!

Jan 2016

•

Verified SHC Patient

All good very pleased.

Dec 2015

•

Verified SHC Patient

Dr. Ganjoo was very friendly but it seemed that she did not review the records and specifically pathology report from the Mayo Clinic which had detailed information about the tumor. This is the reason I do not have confidence in her recommendations. Dr. Ganjoo also did not follow up as she promised with my questions about the pathology report.

Dec 2015

•

Verified SHC Patient

Dr. Kristen Ganjoo is not only a brilliant physician she's a sensitive soul and lucid communicator.

Dec 2015

•

Verified SHC Patient

Dr. Ganjoo is an excellent doctor.

Dec 2015

•

Verified SHC Patient

Dr. Ganjoo was very nice and thorough of her explanation of what was going on with me.

Dec 2015

•

Verified SHC Patient

Sent an email to dr. (as she invited me to) but no answer.

Nov 2015

•

Verified SHC Patient

My husband has had an extremely rare sarcoma & Dr. Ganjoo and Dr. F______ were more than could be expected with information and concern.

Nov 2015

•

Verified SHC Patient

Always excellent.

Nov 2015

•

Verified SHC Patient

I have a wonderful team of doctors. High confidence.

Nov 2015

•

Verified SHC Patient

Caring & compassionate, friendly.

Nov 2015

•

Verified SHC Patient

Best dr - Dr. Ganjoo.

Sep 2015

•

Verified SHC Patient

I am very appreciative that they attended me & they continue attending me in a such a prestigious hospital.

Sep 2015

•

Verified SHC Patient

Dr. Ganjos is excellent- very willing to work with me during this stressful time!

Sep 2015

•

Verified SHC Patient

they are excellent care providers I can tell you how enough that I'm excited to come to visit which is hard to believe because it's not fun being a cancer patient or going to the doctor but they make it bearable and like I said enjoy myself they don't let me suffer I need pain meds right away tell me how to get them they answer my phone calls when I call I actually could get their voice rather than voicemail

Aug 2015

•

Verified SHC Patient

My care provider is very kind sympathetic comforting - loving & concerned about my health.

Jul 2015

•

Verified SHC Patient

I've recommended people to Dr. Ganjoo & they have made appts. with her.

Jul 2015

•

Verified SHC Patient

Dr. Ganjoo is an exceptional provider!

Jul 2015

•

Verified SHC Patient

The staff listened to my concerns and answered my questions thoroughly.

May 2015

•

Verified SHC Patient

Excellent

Apr 2015

•

Verified SHC Patient

have excellent rapport and admiration for Dr Ganjoo

Apr 2015

•

Verified SHC Patient

I am glad I have Dr. Ganjoo as my doctor. I like her a lot.

Feb 2015

•

Verified SHC Patient

In all my years as a patient I have never had a bad experience.

Feb 2015

•

Verified SHC Patient

Dr. Ganjoo is very caring, compassionate and thorough.

Dec 2014

•

Verified SHC Patient

Dr. Ganjoo, her PA & RN are extraordinary people and very good at what they do!

Nov 2014

•

Verified SHC Patient

I am very satisfied with all the spirit of services and attitude especially Dr. Ganjoo, Kristen N. ethics trusted and respected the spirit!

Oct 2014

•

Verified SHC Patient

Left Stanford with a feeling that I would be in the best HANDS VA BAD.

Oct 2014

•

Verified SHC Patient

Telephone call from the doctor on during holiday/decrease dosage, as promised by her nurse never happened. Off hour communication, such as by e-mails, was not good.

Sep 2014

•

Verified SHC Patient

All Dr. Ganjoo's staff is great.

Aug 2014

•

Verified SHC Patient

Dr. Ganjoo was very patient & understanding of my needs & concerns. I was extremely happy to have her as my MD.

Aug 2014

•

Verified SHC Patient

Very good in everything.

Aug 2014

•

Verified SHC Patient

Only issue was making assumptions re: CT scan results before they were final.

Jul 2014

•

Verified SHC Patient

PA this time had difficulty with understanding problems/questions - ESL - heavy accent. MD was great.

Jun 2014

•

Verified SHC Patient

Provide great care, and have great people at Stanford.

Jun 2014

•

Verified SHC Patient

Listens & explains & examined. Could take a week or more to call me back.

Apr 2014

•

Verified SHC Patient

Dr. K. Ganjoo is tops in her field and I was honored to be able to see her.

Mar 2014

•

Verified SHC Patient

Dr. Ganjoo was extremely attentive and explained/answered at.... all my questions.

Feb 2014

•

Verified SHC Patient

Best service every time.

Jan 2014

•

Verified SHC Patient

Provider always gives hope.

Dec 2013

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Kristen N Ganjoo

Sarcoma specialist, Medical oncologist

Get In Touch

Professional Summary

Education & Certifications

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Sarcoma Program in Palo Alto Palo Alto, CA

Sarcoma Program in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(586 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Kristen N Ganjoo

Sarcoma specialist, Medical oncologist

Get In Touch

Professional Summary

Education & Certifications

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Sarcoma Program in Palo Alto Palo Alto, CA

Sarcoma Program in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(586 reviews)

Referring Physicians

PHYSICIAN HELPLINE